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CHAPTER I 
INTRODUCTION 
The purpose of this dissertation is to characterize 
the process by which extracellular proteins are degraded 
by cultured macrophages. The degradation of extracellu-
lar protein occurs within the lysosome. It has been pro-
posed that the lysosome may also be the site of intracel-
lular protein degradation under some conditions. The study 
of extracellular protein degradation may thus be a model 
for some steps in intracellular protein turnover. A study 
of the degradation of extracellular proteins may therefore 
contribute to an understanding of intracellular protein 
turnover and may permit choices to be made between several 
models proposed for the latter process. 
I will begin this introduction by reviewing the cur-
rent literature on intracellular protein degradation, as of 
1981, and will present models that have been proposed to 
explain this process. I will then discuss the degradation 
of extracellular proteins and how this process may be re-
lated to intracellular protein degradation. 
1 
2 
A. Intracellular Protein Degradation 
Intracellular protein degradation is believed to 
serve several important functions in the cell. It can 
enable the cell to adapt to changes in its environment by 
facilitating rapid changes in the concentrations of en-
zymes within the cell. Thus, the more rapidly an enzyme 
is degraded, the faster its intracellular concentration 
can respond to changes in its environment (1, 2). In 
agreement is the observation in liver that enzymes which 
catalyze either the first or the rate-limiting steps in 
metabolic pathways have the shortest apparent half-lives 
( 3) . 
In nutritionally poor environments, protein degra-
dation could enhance cell survival by providing a contin-
ued supply of amino acids for protein synthesis and/or to 
serve as metabolic fuels for ATP formation. During star-
vation, protein degradation has been found to increase in 
bacteria (4-11), yeast (12, 13), and certain mammalian 
cells in culture (14, 15). During fasting by mammals, 
amino acids derived from cellular proteins in muscle and 
liver can be oxidized directly or their carbon skeletons 
can be converted into glucose by the liver and kidney 
(16). 
Another function of protein turnover is probably the 
removal of abnormal proteins within the cell that might 
3 
arise by mutations, errors in gene expression, denatur-
ation, or chemical modification. Mutant proteins, those 
with a single amino acid substitution, were found to be 
degraded at a faster rate than normal proteins in cul-
tured mouse L-cells (17). Abnormal proteins created by 
growing cells in media containing amino acid analogs were 
degraded more rapidly than normal proteins in bacteria 
(18, 19), fibroblasts (20), and hepatoma cells (21, 22). 
The degradative rates of different enzymes within 
bacterial and animal cells can vary widely. Heteroge-
neous rates have been found for membrane and organelle 
proteins (1, 23) as well as soluble proteins (2). In ad-
dition, these rates can vary under different physiologi-
cal conditions. In most cases, degradation appears to be 
a first order process indicating that newly synthesized 
protein is as likely to be degraded as old protein. 
(2, 24, 25, 26). This suggests that for each individual 
protein, molecules are selected at random for degradation. 
There appears to be a correlation between degrad-
ative rates and some physical properties of proteins. 
In rat liver, soluble and membrane proteins composed 
of larger molecular weight subunits turned over more 
rapidly than those with smaller subunits (27-29). 
This relationship did not hold for serum proteins (30). 
4 
However, in the latter case, the proteins must be cleared 
from the circulation before degradation can occur so that 
their turnover rate may be controlled by their rate of 
uptake into tissues. For both serum and tissue proteins 
a correlation may exist between their isoelectric points 
and half-lives (30-32), with the more acid proteins being 
degraded more rapidly. The relationships between degrada-
tion rate, subunit molecular weight, and isoelectric point 
were also found in the mouse blastocyst (33). A relation-
ship may also exist between the hydrophobicity of a pro-
tein and its rate of turnover (34, 35) with the more hy-
drophobic molecules being degraded at a faster rate. It 
was suggested that this could be due to an increased asso-
ciation of hydrophobic proteins with cellular membranes, 
leading to a preferential uptake into lysosomes. 
Conformation also appears to affect the rate of pro-
tein turnover. Thus, it has been suggested that the in-
creased rates of degradation which have been observed for 
mutant or modified proteins (18-22, 32) may be a conse-
quence of their abnormal and possibly less stable conforma-
tions. In bacterial mutants, incomplete chains of S-ga-
lactosidase which differ in conformation, as determined 
by their ability to cross-react with antibody, ware degrad-
ed at different rates (36). Although a small correlation 
5 
existed between chain length and half-life, a much 
stronger correlation existed between conformation and 
half-life. Chains with conformations similar to that of 
the native protein, as determined by antibody cross-reac-
tivity, were degraded more slowly. Additional evidence 
for the importance of protein conformation on degradative 
rates was shown by studies of the effects of bound ligands 
on protein half-lives. Tryptophan pyrrolase (37), serum 
albumin (38), aspartate transcarbamylase (39), staphylo-
coccal nuclease (40), and ribonuclease (41) were observed 
to be degraded more slowly upon the binding of specific 
ligands in vivo. This effect was attributed to changes in 
the conformation and/or stabilization of the conformation 
of the proteins caused by ligand binding (42). Similarly, 
both hemoglobin and glycogen phosphorylase were shown to 
be degraded more rapidly in vitro on the binding of oxygen 
(43) and glucose (44) respectively. Thus, the concentra-
tion of various ligands within the cell, such as sub-
strates, cofactors, inorganic ions, etc., could regulate 
the rate of degradation of individual proteins. 
One study, however, appears to dispute the effect of 
conformation on turnover rate (45). Various tyrosine-ami-
no-transferases containing different amino acid analogs 
were found to be less heat stable and only 2/3 as 
6 
catalytically active when compared to the native protein 
but their turnover rates in rat liver were found to be 
similar. 
The mechanisms by which hormones and metabolites 
regulate the rates of protein turnover have been investi-
gated in cells in culture, in tissue slices, and in per-
fused organs. Isolated hepatocytes labeled with 3H-amino 
acids degrade about 4.5% of their cellular protein per 
hour (46). This degradation was decreased by inhibitors 
of ATP formation and by the addition of insulin and sev-
eral aminG acids to the medium or perfusate. 
The control of protein turnover by insulin, however, 
may be an involved process since it has been found to in-
crease protein s;mthesis as well as decrease degradation 
in tissues (47, 48) and in cultured fibroblasts (49). 
Insulin appears to antagonize the adenyl cyclase system, 
as do oxytocin and prostaglandins, while hormones such as 
epinephrine, glucagon, ACTH, TSH, LH, secretin, and GH 
stimulate it (50-57). As will be explained later, cAMP 
appears to be involved in endocytosis and, in the thyroid, 
TSH has been found to increase endocytosis (58). In con-
trast to insulin, glucagon appears to stimulate protein 
degradation in the liver (59) . This effect annears to be 
.t .1. 
7 
secondary to a glucagon induced depletion in the cellular 
levels of several free amino acids, notably glutamate 
( 60). 
Intracellular protein degradation also appears to be 
regulated by the availability of ATP. Murakami, et al., 
(61) looked at the degradation of proteins with abnormal 
conformations using cell-free extracts from E. Coli and 
found it to be an energy dependent process. Incomplete 
fragments of S-galactosidase generated through nremature 
termination of protein synthesis were degraded in this 
system by a process that depended on a continued avail-
ability of ATP. Cell free extracts from E. Coli also 
degraded 14c-methylapohemoglobin in an ATP dependent fash-
ion. Other nucleotide triphosphates and ADP were less 
stimulatory than ATP while AMP, NAD, NADH, guanosine 
tetraphosphate and a., B, and y-methylene ATP did not af-
ford significant stimulation. The requirement for ATP 
could not be explained by a requirement for protein syn-
thesis as the stimulation by ATP was not affected by chlo-
ramphenicol (62). The pH optimum for this ATP dependent 
proteolytic activity was 8.0. The authors indicated the 
need for further studies to explain this ATP requirement. 
Kowit and Goldberg (63) , in studying the degradation 
8 
of a specific mutant S-galactosidase (X-90) in~· Coli, 
were able to demonstrate that high energy phosphate was 
required both for the initial proteolytic cleavage as 
well as for the subsequent hydrolysis of the degradative 
intermediates. 
Extracts of E. Coli were purified and this ATP 
stimulating protease was found to have a molecular weight 
of 115,000. Reticulocytes also appear to have an ATP 
dependent protease activity and it appears to be a dis-
tinct cellular enzyme of non-lysosomal origins (62). It 
has an optimal pH of 7.8 and remains in the supernatant 
even after centrifugation at lOO,OOOg for several hours. 
In contrast, fractions of cell homogenates enriched in 
lysosomes had little proteolytic activity at pH 7.8 and 
showed no stimulation by ATP. The ATP dependent proteo-
lytic activity was not sensitive to the protease inhib-
itors pepstatin, leupeptin, or chymostatin which will 
inhibit the lysosomal cysteine proteases. 
ATP could stimulate protein degradation by partici-
pating directly in the catalytic process. This could in-
volve an ATP dependent transformation of the substrate, 
thereby increasing its susceptibility to proteolysis. 
Alternatively, ATP could act to modify the protease 
9 
directly by inducing a change in protein conformation, by 
participating in the reversible chemical modification of 
the protease, or by participating in the inactivation of 
an endogenous inhibitor. 
In order to determine the chemical basis of the ATP 
requirement in intracellular protein turnover, Hershko 
and his associates have recently partially purified and 
characterized an ATP dependent proteinase system from 
rabbit reticulocytes (64). They found this system to be 
composed of several components. One component is a 
heat-stable polypeptide (APF-1) which has subsequently 
been identified as ubiquitin (65), a protein discovered 
earlier in many tissues but whose function was not known. 
During protein degradation, this polypeptide appears to 
become covalently linked to the protein substrate in an 
ATP dependent fashion forming a high molecular weight 
conjugate. This conjugation reaction is inhibited by 
N-ethylmaleimide. UTP and GTP could not substitute for 
ATP in this system. These properties of conjugate for-
mation are similar to those of overall ATP dependent 
protein breakdown in the same system suggesting that the 
formation of a substrate-ubiquitin conjugate could be 
obligatory intermediates in the degradative process, A 
10 
mechanism for this process was proposed (66) . The scheme 
is as follows: 
PROTEIN ~-------------- (APF)n-PROTEIN 
nATP ,[ + 
nAPF f----__ ___ 
--------
nAPF-X & AMINO ACIDS 
Conjugation involves an enzymically catalyzed synthesis of 
a covalent bond between APF-1 and the E-NH2 group of 
lysine in polypeptides and proteins. The portion of the 
APF-1 molecule that is involved in conjugation appears to 
be the COOH-terminal glycine (153). This enzymic activ-
ity, "APF-1-protein amide synthetase," is either preces-
sive or has a high preference for protein previously con-
jugated with APF-1, as derivatives with more than one 
APF-1 molecule will appear under conditions of excess free 
substrate protein. ATP is specifically required for this 
reaction. A reverse reaction, the generation of APF-1 
from APF-1 protein, is catalyzed by an amidase. The 
amidase does not require ATP. (66). 
(APF) -Protein is cleaved by peptidases that act on 
n 
(APF-l)n derivatives to yield nAPF-X where X is lysine or 
a 3mall peptide. The Apf-1 is regenerated by an amidase 
( 66) . 
11 
It remains to be demonstrated whether such a sys-
tem operates in eukaryotic cells other than reticulocytes. 
In addition, studies of the purified ATP dependent proteo-
lytic system from E. Coli suggests that it may be very 
different from the rabbit reticulocyte system (154, 155). 
Poole and Wibo (67) studied protein turnover in 
rat fibroblasts in culture and found that many cellular 
proteins could be divided into two categories; those with 
short half-lives (approximately 1-10 hours) and those with 
long half-lives. They observed that fluoride, iodo-
acetate, and chloroquine affected the rates of degradation 
of both types of proteins to similar extents (68). These 
compounds all inhibit proteolysis within the lysosome. 
In contrast, variations in the composition of the culture 
medium affected the degradation of proteins with long 
half-lives only. Their degradation was inhibited by in-
creasing levels of serum in the culture media and en-
hanced by conditioned media. Addition of amino acids 
to the medium also inhibited the degradation of the pro-
teins with long half-lives. 
The requirement for ATP for the degradation of the 
two classes of proteins is not clear. Fluoride and iodo-
acetate decrease cellular ATP levels but the inhibition 
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of protein degradation observed did not parallel their 
effects on the cellular ATP levels. In general, these 
results could be interpreted to indicate that different 
pathways exist for the degradation of proteins with slow 
and fast turnover rates but that these pathways might 
share one or more steps in common (68). It was further 
suggested that the degradation of the more stable pro-
teins involves a step not necessary for the degradation 
of more labile proteins. In another study (69), it was 
found that media deficient in serum, amino acids, phos-
phate, or glucose caused a twofold increase in the rate 
of degradation of long-lived cellular protein but had no 
effect on the rate of degradation of proteins with short 
half-lives. Insulin, dexamethasone, and fibroblast 
growth factor acted synergistically to inhibit the en-
hanced protein degradation caused by serum deprivation 
and to stimulate thymidine incorporation to levels sim-
ilar to that seen with complete media containing serum. 
The enhanced proteolysis caused by serum-deficient media 
(long-lived protein) was found to be inhibited by 
vinblastine, a microtubule inhibitor, but vinblastine 
had no effect on basal proteolysis (70). Therefore, only 
enhanced proteolysis seemed to involve microtubules. 
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R. B. Hendil (71) found that the rates of degradation of 
protein with long and short half-lives were increased in 
fibroblasts maintained at a high cell density. In con-
trast, protein degradation in SV 40 transformed cells 
was affected by serum deprivation but had lost its re-
sponse to high cell density. 
The participation of the lysosomes in the degrada-
tion of long and short-lived proteins in isolated rat 
hepatocytes was investigated using reagents that inhibit 
the lysosomal digestion of protein (72) . Ammonia inhib-
ited by 70% the degradation of long half-life proteins 
but only inhibited the degradation of short half-life 
proteins by 45%. The results for chloroquine and meth-
ylamine, both of which are lysosomotropic reagents that 
concentrate in the lysosomes, were the same as those for 
ammonia. In addition, the inhibitions produced by these 
reagents were not additive. On this basis, it was con-
cluded that there may be more than one pathway for the 
degradation of cellular proteins and these pathways may 
make different contributions to the degradation of long 
and short-lived proteins. 
In a second study, leupeptin, an inhibitor of lyso-
somal cysteine proteinases, was also found to be unable 
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to completely inhibit protein turnover. In addition, the 
inhibition it produced was not additive with that pro-
duced by ammonia. From these results it was hypothesized 
that a non-lysosomal pathway may also contribute to cel-
lular protein turnover. In addition, it was hypothesized 
that short-lived proteins were degraded mainly by a 
non-lysosomal pathway since the lysosomal protease inhib-
itors did not significantly affect the degradation of 
most of these proteins. The majority of the stable pro-
teins appeared to be degraded by a lysosomal pathway as 
lysosomal protease inhibitors decreased their rate of 
breakdown by 70~~ (72) . 
Neff et al. (73) also studied the degradation of 
long and short-lived proteins in rat hepatocytes. They 
found that the protease inhibitors leupeptin, chymostatin, 
and antipain inhibited the degradation of long-lived pro-
teins by 20-30%. A similar inhibition of degradation of 
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the extracellular protein I-asialofetiun was also 
observed. In contrast, leupeptin, chymostatin, and anti-
pain did not significantly inhibit the degradation of pro-
teins with short half-lives or abnormal proteins contain-
ing an amino acid analog. These results are also con-
sistent with the existence of multiple pathways of 
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cellular protein breakdown which make different contribu-
tions to the degradation of proteins with long and short 
half-lives. 
In summary, these studies suggest that normal cellu-
lar proteins fall into at least two populations: those 
which turn over slowly and those which turn over rapidly. 
It also appears that the pathways for their degradation 
may be different, although they may share one or more 
steps in common. Long-lived proteins may be degraded in 
lysosomes, as are extracellular proteins, while short-
lived proteins may undergo initial degradation in the 
cytosol. The pathway for the degradation of short-lived 
proteins may resemble that of abnormal proteins which 
could arise from errors in translation, premature chain 
termination, or incorporation of an amino acid analog 
since abnormal proteins are also rapidly degraded (74). 
Normal proteins which turn over rapidly may be enzymes 
which play a regulatory role in metabolism (75). 
The mechanism. by vJhich abnormal proteins are degrad-
ed has been investigated in ~· Coli and in cultured mam-
malian cells (17, 18, 20-22). With E. Coli, abnormal 
proteins were degraded more rapidly than normal proteins 
by a process which is energy dependent. In addition, 
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while the degradation rates for normal proteins differed 
in growing and non-growing cells, the rates of degrada-
tion of abnormal proteins were similar under both con-
ditions. The abnormal proteins were caused by errors in 
translation, by growth in the presence of amino acid 
analogs, and by puromycin which causes premature release 
of nascent proteins from the ribosome. Similar phenom-
ena were also obtained in mammalian cells in culture 
(17, 18, 20-22). In addition, aging in cultured fibro-
blasts, which has been hypothesized to cause an increased 
accumulation of abnormal proteins, also causes an in-
creased rate of proteolysis of cellular proteins (20). 
Although some facts are known about intracellular 
protein degradation and the effects of various factors 
on its rate, the exact cellular mechanism is in doubt. 
Where does the degradation take Dlace? Studies with 
reticulocytes and prokary9tes suggest, that degradation. 
might occur outside the lysosome (32, 76). Prokaryotes, 
which are capable of degrading intrq.cellular proteins, 
lack lysosomes. The protease activity of reticulocytes 
against abnormal globin was found to be due to a soluble 
extra lysosomal system stimulated by ATP and having a 
basic pH optimum. 
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There is, however, strong evidence for the involve-
ment of lysosomes in eukaryotic intracellular protein 
turnover. Liver perfusion studies showed the inhibition 
of protein degradation by pepstatin, a specific inhib-
itor of cathepsin D (77). This result is supported by 
additional perfusion studies which demonstrated that 
conditions which affect lysosomal proteolysis also affect 
cellular protein turnover in a similar manner. (78, 79). 
In addition, lysosomes isolated from liver perfused under 
conditions of increased protein turnover show differences 
in their densities and fragilities from those isolated 
under conditions of basal turnover (156). Measurements 
of the size of the lysosomal pool and volume of the 
lysosomal compartment in the perfused liver indicate 
that these increase under conditions of enhanced cel-
lular protein degradation (157, 158). Calculations of 
the rate of lysosomal protein degradation, based on the 
size of the lysosomal substrate pool under various con-
ditions, has been cited as evidence for the sole partic-
ipation of lysosomes in cellular orotein turnover. In 
vitro studies also suggest the involvement of lysosomal 
enzymes in intracellular protein degradation since the 
relative rates of degradation of various proteins by 
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lysosomal enzymes in vitro were similar to their relative 
in vivo degradation rates. In vivo studies with lysosomal 
protease inhibitors (46, 85-87) and agents that cause 
lysosomal dysfunction, such as chloroquine, (46, 85, 
88-90) also support the involvement of lysosomes in pro-
tein degradation in the cell. 
The importance of lysosomes in protein degradation, 
in the diseased state, was shown by the delayed degener-
ation of dystrophic muscle in cell cultures in the 
presence of pepstatin, leupeptin, and antipain (91) and 
in vivo in the presence of pepstatin and leupeptin (92). 
However, in all cases, lysosomal protease inhibitors and 
lysosomotropic reagents, eithe= singly or in combination, 
are incapable of completely abolishing intracellular 
protein degradation. This perhaps implies the contribu-
tion of an extralysosomal pathway. 
If eukaryotic protein degradation occurs in the 
lysosome, how are proteins transported into the lysosome 
from other cellular compartments? One possibility in-
volves a kind of internal phagocytosis which has been 
called autophagy. The ATP reauirement of ?rotein turnover 
may thus be due to an energy dependence for autophagy. 
One ~roblem with this hypothesis is that it has difficulty 
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accounting for the observation that the rates of turnover 
of proteins are quite variable. Even many of the proteins 
of a given cellular organelle show varied turnover rates 
indicating that the organelle is not degraded as a unit. 
To accommodate these observations, it has been proposed 
that proteins which can bind to the lysosomal membrance 
may be internalized more rapidly and thus are more rapidly 
degraded. It has been shown that proteins with short 
half-lives accumulate preferentially at water-organic 
solve~t interphases when aqueous liver homogenates are 
incubated with an immiscible organic solvent (93) and tend 
to associate preferentially with lysosomal pellets (94). 
In agreement, proteins with more rapid turnover rates 
appear superficially more hydrophobic and bind prefer-
entially to hydrophobic chromatography resins (34, 35). 
In addition, hormones that decrease protein degradation, 
such as insulin, have been show~ to decrease cAMP, which 
is involved in endocytosis. However, it has also been 
reported that observation, which causes increased protein 
turnover, largely abolishes the differences in the deg-
radation rates of various cellular proteins. Since 
starvation induced proteolysis is believed to be 
autophagic and to involve lysosomes, this finding has 
been interpreted to mean that basal protein turnover 
occurs by a second pathway which is more sensitive to 
the physical properties of the cellular protein sub-
strate (94b). 
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An alternative model involving lysosomes has been 
proposed to account for differences in the rate of deg-
radation of cellular protein. According to this model, 
a protein's natural susceptibility to degradation by 
lysosomal proteases may determine its biological half-
life. Many studies with lysosomal extracts and intact 
cells offer some support for this hypothesis (87, 95-98). 
It was found that the half-lives of proteins in vivo 
correlated roughly with their rates of degradation in 
vitro. There was also found to be some correlation be-
tween the activity of lysosomal proteases and the rate 
of intracellular protein degradation. It was postulated 
that the rate-limiting steps of protein turnover occur 
in the lysosome and that differences in degradative rates 
between various proteins reflect inherent differences 
in their susceptibilities to lysosomal proteases. One 
problem with this hypothesis is that it requires that a 
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protein which escapes digestion can exit the lysosome. 
According to this hypothesis, proteins which are degraded 
more slowly by lysosomal enzymes would have a greater 
probability of escaping the organelle intact. Segal et al. 
(98) demonstrated that yeast invertase could escape intact 
from the lysosomes and proposed a model for intracellular 
protein degradation (Figure I). Step number 3, the rate 
of degradation to large peptides by lysosomal proteases, 
is hypothesized to be rate limiting. 
In this model, a protein can leave as well as enter 
the lysosome intact (Step 2) . The protein would then be 
degraded to large peptides (Step 3). Step 3, the rate of 
degradation by lysosomal proteases, is hypothesized to be 
rate limiting under some circumstances. The protein can 
also be altered in the cytoplasm (Step 1) to become sus-
ceptible to possible extra-lysosomal degradation (Step 2) . 
The large peptides produced in Step 2 would then enter 
the lysosome where they would be degraded further. The 
final product of degradation would be the amino acids 
that are released from the lysosome. 
Haider and Segal (99) demonstrated that substances 
that affect in vivo turnover of proteins were also capable 
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Figure 1. Model for intracellular protein degradation. 
Native protein can enter the lysosome directly (Step 2) 
or after modification in the cytoplasm (Step 1) . The 
modified proteins either enter the lysosome or are 
I I 
partially degraded (Steps 1, 2 , and 3 ) . The intact 
proteins in the lysosome are degraded to large peptides 
(Step 3). The large peptides are further degraded in 
the lysosome. The resulting amino acids are then re-
leased from the lysosomes. The active, native protein 
is able to escape degradation by exiting the lysosome 
before (Step 3) has occurred. 
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of modulating degradation of protein in isolated lyso-
somes as well and they formulated equations to explain 
the rates they observed (Figure 2). In their model, 
there is non-differentiated engulfment followed by 
enzymic inactivation. In Figure 2, Co equals the con-
centration of protein, Ci equals its concentration 
inside the lysosome, and k 1 is the rate constant de-
scribing the transport of the protein into the lysosome. 
The p~otein can also escape the lysosome with a rate 
constant of k 2 or it can be degraded by the lysosomal 
proteases with a rate constant of k3 . The specific 
removal rate (ksp) of a protein from a cell is there-
fore dependent on the rates of these three processes 
and is given by 
ksp = kl k3 
k2 + k3 
under steady state conditions. When k3 >> k2, rate of 
degradation much greater than rate of exit from the lyso-
somes, the specific removal rate will equal k 1 , the rate 
of entry into the lysosome. Substances that affect k3 
will have only small effects on the turnover of protein. 
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Figure 2. Proposed equations describing intracellular 
protein turnover. Co represents the concentration of 
a protein in the cytoplasm while Ci represents its con-
centration within the lysosome. The rate constants k1 
and k 2 refer to the rate of entry and exit of the pro-
tein from the lysosome. The rate of intralysosomal 
degradation of the protein is given as k3 . The removal 
of a protein from the cell is therefore described by 
k the specific removal rate, and is equal to k1 k 3 sp, 
------->--". k 3 ~ D d . P d Co v~ -------,~ egra at~on ro ucts 
-E -
kl k3 
ksp (Specific Removal Rate) = ~~~---­kz + k3 
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If k 2 >> k3 , ksp is approximately equal to (k1/k2) k 3 
and substances that affect k 2 and k3 will now also 
affect the turnover rate as well. 
One result that supports the escape of peptides 
from the lysosome is the finding that lysosomal ex-
tracts from liver are incapable of completely digesting 
protein substrates (100). Further degradation occurred 
uoon the addition of the high s~eed supernatent at pH 8. 
It was postulated that small peptides were transported 
or diffused across the lysosomal membrane to be further 
degraded in the cytoplasm. However, in experiments with 
isolated lysosomes (101) and lysates from macrophages 
(102), it was found that there was a limit to the molec-
ular size of solute molecules which can cross the lyso-
somal membrane. Polypeptides would not be able to escape. 
Only small molecules could cross the lysosomal membrane. 
Thus, it appears that the results of Segal et al. 
(98) which demonstrated the transfer of invertase from 
the lysosome to the cytosol may represent an exception. 
At present, there is no evidence for an appreciable 
transfer of intact proteins from the lysosome to the 
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cytosol as a generalized phenomenon. 
It has also been argued that protein denaturation 
may be the rate determining step in protein turnover 
(103). On incubating proteins with lysosomal extracts 
in vitro, it was found that denaturation was required 
for extensive digestion of this mixture by lysosomal 
hydrolases. The rate of denaturation of a protein in 
vivo may therefore determine its rate of degradation. 
Although this can account for variable turnover rates 
for proteins, it does not expiain how denatured pro-
teins might be preferentially taken up into lysosomes. 
However, it is possible that denaturation could expose 
the hydrophobic regions of a protein which could inter-
act with the lysosomal membrane causing increased uptake 
into the lysosomes. 
The model proposed in Figure I proposes that while 
early steps in protein degradation may occur in the cyto-
sol, the latter stages occur primarily in the lysosome. 
In contradiction, some evidence exists for an independent 
non-lysosomal pathway for protein degradation. This 
includes: the finding that lysosomal protease inhibitors 
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can not completely block protein degradation; the obser-
vations that there exists two classes of proteins whose 
degradation rates are differentially affected by hormones 
and which show differential susceptibilities to the action 
of lysosomal protease inhibitors; the finding that inhib-
itors of ATP formation block basal protein turnover but 
not the augmented protein turnover observed in nutrition-
ally deprived cells; the observation that starvation abol-
ishes differences in the degradation rate of cellular pro-
tein; and the discovery of a non-lysosomal proteolytic 
activity in the extracts of reticuloyctes and possibly 
liver. 
A model for the degradation of cellular protein by 
a dual pathway has recently been proposed by Knowles and 
Ballard (22) . In studies of the degradation of normal 
proteins and aberrant proteins containing an amino acid 
analog, 1-canavanine, in hepatoma cells, some evidence 
was obtained for the model shown in Figure 3. It was 
found that normal proteins were degraded more rapidly 
than native proteins. Furthermore, in contrast with 
normal proteins the degradation of abnormal proteins 
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Figure 3. Dual pathway model for intracellular protein 
degradation. The active pathway (Pathway A) involves 
nrotein uptake into and degradation by lysosomes. This 
pathway degrades short and long lived proteins at sim-
ilar relative rates which are determined by the rate of 
autophagy. The inactive pathway (Pathway B) would de-
grade various cellular proteins at different rates which 
would depend on their rates of denaturation and thus on 
their inherant stabilities. 
This stability could be modulated by ligands. The 
first and rate determining step in this pathway, B1 , in-
volves denaturation of the protein. The denatured pro-
tein is then degraded in Step B2 . Pathway B is suggested 
to be extralysosomal. The active pathway, pathway A, be-
comes activated on nutritional step-down as a consequence 
of increased autophagy. 
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was not inhibited by lysosomal protease inhibitors, fetal 
calf serum, insulin, or cyclohexamide. To account for 
these observations, it was proposed that all proteins 
could be degraded by an active pathway involving autophagy 
(Pathway A). This pathway could be inhibited by lysosomal 
protease inhibitors and lysosomotropic reagents. 
It was proposed that the lysosomal pathway degrades 
the different classes of cellular proteins at similar 
relative rates. Therefore, to account for the observation 
that various proteins are degraded at different rates, it 
was proposed that a second pathway, termed the inactive 
pathway, is also present. This pathway, which was hypoth-
esized to degrade abnormal or inactive proteins by a 
process which did not involve lysosomes, was presumed to 
be regulated by the intrinsic stability of each protein. 
Accordingly, protein breakdown is initiated by denatu-
ration (Step B1). The rate of denaturation would reflect 
the inherent stability of each protein molecule and would 
vary, thereby accounting for differences in degradation 
rates between proteins. In addition, the stability of 
various proteins could be modulated by ligands. According 
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to this hypothesis, short-lived proteins are those which 
are rapidly denatured or inactivated in vivo. Step B2 
depicts the degradation of denatured proteins to free 
amino acids. It is suggested that the inactive pathway, 
Pathway B, does not involve lysosomes because the rates 
of degradation of short-lived molecules are not signifi-
cantly affected by the lysosomal protease inhibitors. 
This proposal is attractive because it provides a 
means by which the cell may remove abnormal proteins which 
is free from the regulatory constraints associated with 
the physiological degradation of normal proteins. 
In summary, the process of intracellular protein 
degradation is not completely understood; there is dis-
agreement as to exactly where in the cell degradation 
occurs, whether one or more pathways participate, and on 
the nature of the steps involved. At least some steps 
may occur in lysosomes. However, mechanisms in which the 
lysosome is the exclusive site of cellular protein degra-
dation now seem untenable. 
Essential components of any explanation of protein 
degradation must account for differences in the turnover 
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rates for various cellular proteins. It has been sug-
gested that the rate of turnover of an individual protein 
is determined by its intrinsic sensitivity toward endog-
enous proteases (80-84). However, why different proteins 
show different susceptibilities toward digestion is un-
known. In addition, the sequence of events in protein 
degradation within the lysosome is also only poorly de-
scribed. Information about lysosomal protein degradation 
may be obtained by studying the degradation of extracel-
lular proteins since these appear to be taken up and de-
graded exclusively within these organelle. This approach 
also permits one to determine possible correlations be-
tween known structural features of proteins and their in-
trinsic sensitivity toward digestion in lysosomes and to 
study a process which may be a model for one or more 
steps in intracellular protein turnover. 
B. Extracellular Protein Degradation 
Extracellular proteins are taken up by cells in cul-
ture by endocytosis. Ehrenreich and Cohn (104) demon-
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strated that the conditions for uptake of I-HSA by 
macrophages correlated well with the conditions favorable 
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for pinocytosis; fetal calf serum (50%) and dextran sul-
fate enhanced uptake while parafluorophenylalanine, which 
inhibits pinosome formation, had an inhibitory effect. 
Uptake of non-digestible material as well as denatured 
albumin by macrophages demonstrated that uptake was linear 
with time for 7 hours (105). Similar results were also 
obtained with sarcoma cells (106). Experiments utilizing 
rat yolk-sac showed that extracellular protein enters in 
the liquid phase. Denaturation of the protein increased 
its uptake by permitting its binding to cell surface com-
ponents (107), a result that was also duplicated in other 
experiments with yolk sacs (108). It was suggested that 
the digestive capacity of the lysosomes exceeded the caDac-
ity of cells to take up proteins, and therefore, pino-
cytosis was the rate determining step in the processing of 
exogenous proteins. 
Factors influencing the rate of uptake of extracel-
lular protein, other than protein structure, were also in-
vestigated. Inhibitors of glycolysis and respiration re-
duced pinocytosis in macrophages. Protein synthesis is 
also required for pinocytosis since it was inhibited by 
36 
puromycin and P-fluorophenylalanine (109). A reduction 
in pinocytosis was also found as the temperature was 
lowered. Pinocytosis is stimulated by high concentra-
tions of calf serum (110, 111) as well as by anionic mol-
ecules (112). It is also stimulated by cAMP, ADP, and 
ATP (113) . Catecholamines and prostaglandins E1 PGA1 
, ' 
and Fz which elevate ck~ levels, also stimulate pino-
' 
cytosis (114). A similar effect was also observed for 
theophylline and papaverine, inhibitors of cyclic nucleo-
phosphodiesterase. Other hormones which affect cellular 
cAMP levels (47-58) would therefore affect pinocytosis. 
Endocytosis of digestible material causes an in-
crease in the activity of the lysosomal enzymes. This 
appears to involve de novo protein synthesis since this 
induction is inhibited by puromycin (115). The induction 
is also inhibited by colchicine (116) and stimulated by 
chloroquine (117). This induction of digestive enzymes 
does not occur after endocytosis of non-digestible materi-
al (115). 
After uptake, endocytosed material is localized 
within the lysosome (118-122) where the endocytosed pro-
tein is then digested by lysosomal proteases. In vitro 
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experiments demonstrated the ability of lysosomal protease 
to digest proteins. Studies using lysosomal orotease in-
hibitors showed the importance of cathepsins B1 C, and D 
' 
for protein degradation (123) . The importance of cathepsin 
D was also shown by studies utilizing an antiserum to the 
enzyme that inhibited protein degradation in cultured 
cells (124). 
Degradation of extracellular proteins pre-loaded in 
macrophages was found not to require ongoing pinocytosis, 
oxidative phosphorylation, or protein synthesis but was 
found to be temperature dependent (104). In contrast, in 
liver slices it was found that degradation of extracel-
lular protein in lysosomes does require ATP, as inhibitors 
of energy formation were also able to partially inhibit 
protein degradation (125). These liver slices were col-
lected 30 minutes after intravenous injection of Formal-
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dehyde treated I-BSA into mice. The degradation was 
studied for 60 minutes. However, there was only 60% cell 
viability after 60 minute incubation. Studies with 
isolated lysosomes (101) and cultured macrophages (102), 
as discussed previously, suggested that digestion of 
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protein within the lysosome is complete as small peptides 
are too large to escape from the lysosome. Proof of this 
comes from the analysis, by paper and column chromatogra-
phy, of the products released when cultured cells 
(104, 126-128) and isolated phagosomes, vesicles that ap-
pear as the result of phagocytosis (129), degraded exoge-
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nous I-labeled protein. In each case, the only labeled 
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oroducts released into the medium are free I, mono-
iodotyrosine, diodotyrosine, and glycyliodotyrosine; no 
intermediate molecular weight products were observed. 
In the isolated phagosomes, the degradation was inhibited 
by sucrose and salts which is similar to the effect that 
these two substances have on the degradation of pinocy-
tosed proteins in vivo. 
It has frequently been observed that a significant 
quantity of material endocytosed by cultured cells may 
subsequently be released into the media. Approximately 
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20% of the total colloidal Au-gold taken up by macro-
phages is released into the media within the first hour, 
and thereafter, very little further release is seen in 
subsequent hours (105). A similar result was obtained for 
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I-PVP. The cells therefore appear to regurgitate some 
undigested material in an initial period following uptake. 
A qualitatively similar result has been obtained on feed-
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ing Ir to macrophages. However, in this case, 50% of 
the label was released from the cells in the first day 
following uptake but no more was released for the next 21 
days (130). 
Degradation of extracellular protein by cultured 
cells has been examined by two methods. Steinman and Cohn 
(131) fed soluble horseradish peroxidase to mouse peri-
toneal macrophages and studied the loss of peroxidase ac-
tivity from macrophages with time. The half-life ob-
tained by this method was approximately 8 hours. In con-
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trast, when I-labeled peroxidase was used, the half-life 
based on the loss of radioactivity from the cells was 20 
to 30 hours. The discrepancy in rates could be due to the 
larger number of peptide bond cleavages required before 
the label can exit the cell compared with the number of 
peptide bond cleavages required for inactivation. Studies 
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utilizing I-albumin (104, 126) found that the loss of 
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label from the cells was biphasic, a fast phase followed 
by a slower one. The rate of loss was increased when the 
concentration of serum in the media was raised. After 24 
hours, 75% of the labeled albumin originally present in 
the cells was released. 
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To make sure that the release of I activity into 
the media was due to protein degradation, Ehrenreich and 
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Cohn (127) studied the degeneration of I-Hb and 
leucine- 3H-Hb by macrophages and found the results to be 
identical. The degradation of Hb was found to be slower 
than that of albumin as only 50% of the label was released 
from the cells after 24 hours. The isotope lost by the 
cells could be accounted for as TCA - soluble isotope ap-
pearing in the medium. 
C. Purpose 
The purpose of this study was two-fold. First we 
wanted to characterize the process by which extracellular 
proteins, incorporated into macrophages by endocytosis, 
are degraded. This process takes place in lysosomes, 
which are also possible sites of intracellular protein 
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degradation. In the model for intracellular degradation 
illustrated in Figure 2, the degradation of long-lived 
proteins is suggested to occur primarily in the lysosome. 
In addition, it has been suggested that the rate of turn-
over of many intracellular proteins may be determined by 
their rate of degradation in the lysosome. Therefore, it 
was hoped that studies of protein degradation following 
pinocytosis might contribute to an eventual understanding 
of the mechanism of intracellular protein turnover. In 
addition, it was felt that these studies could contribute 
to an understanding of the structural features of pro-
teins which control their rates of proteolytic degrada-
tion. However, in order to carry out studies on the cel-
lular degradation of extracellular proteins, it was first 
necessary to develop a methodology that required a minimum 
amount of cells, media, and labeled protein substrates and 
which yielded reliable and reproducible results. 
CHAPTER II 
EXPERIMENTAL 
A. Materials 
1. Substrates for Cellular Uptake and Degradation 
Dextran, human serum albumin, cytochrome c, 
phosphorylase b, hemoglobin, arginase, ribonuclease, 
B-galactosidase, thyroglobulin, catalase, and enolase 
were obtained from Sigma Chemical Company. Ovalbumin 
was a product of Nutritional Biochemical Corporation. 
Dextran-sulfate (molecular weight 2 x 106) was from 
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Pharrnacia Fine Chemicals and I-bovine serum albumin 
was obtained from New England Nuclear. 
2. Labeling Reagents 
125 14 3 14 
Na I, C-glycine, H-glycine and C-acetic 
anhydride were obtained from Amersham-Searle. Cyanogen 
bromide was purchased from Aldrich Chemical Company. 
Chlorarnine-T and lactoperoxidase were products of Sigma 
Chemical Company and the enzymobead kit for radioiodi-
nation was obtained from Bio-Rad Labor~tories. 
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3. Inhibitors 
Antipain, leupeptin, and pepstatin were products of 
the Protein Research Foundation. Soybean trypsin inhibi-
tor (Kunitz) was from Worthington. Chloroquine was ob-
tained from Sigma Chemical Company. 
4. Cell Culture Material 
Lux polystyrene tissues culture petri dishes 
(35 x 10 mm) and multiplates were obtained from 
Microbiological Associates. Media 199 (1 x, with Earles 
salts, 2.2 g/1 sodium bicarbonate, and 1-glutamine), 
Earles balanced salt solution, virus screened fetal calf 
serum, penicillin-streptomycin sulfate, and 1-glutamine 
were from Grand Island Biological Company. 
Media was supplemented with fetal calf serum 
(1-50%) penicillin (1,000 units /ml), streptomycin sulfate 
(1,000 ~g/ml), and 1-glutamine (2m~) before use. The 
media used in the uptake of radioactively labeled sub-
strates contained 50% fetal calf serum. The media used in 
measuring rates of degradation of pinocytosed proteins 
contained varying amounts of fetal calf serum although 
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experiments were most commonly performed with media con-
taining 1% fetal calf serum. All cells were maintained 
in a Forma Scientifica co2 incubator in an atmosphere of 
5% co 2 and at 37°C. 
5. Gel Chromatography 
Sephadex G-25, G-50, and G-75 were from Pharmacia 
Fine Chemicals. Affigel-Blue was obtained from Bio-Rad 
Laboratories. 
6. Electrophoresis 
Electrophoresis on agarose film was done with the 
Corning cassette electrophoresis system. For poly-
acrylamide disc gel electrophoresis, acrylamide, 
methyl-bis-acrylamide, and TEMED were obtained from 
Eastman Kodak Company and sodium doedecyl sulfate was a 
product of Sigma Chemical Company. 
7. Miscellaneous 
Eight-week-old male Swiss mice were obtained from 
Scientific Small Company. Fibroblasts, low passage baby 
hamster kidney cells (BHK-21/Clone 13), were a gift from 
Dr. Gene Majors. Freund's complete adjuvant was obtained 
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from Grand Island Biological Company. Acrodisc filters 
(0.2~m) were from Gelman and dialysis tubing was obtained 
from Fisher Scientific Company. Trypsin was obtained 
fro~ Sigma Chemical Company. 
B. Methods 
1. Synthesis of Labeled Substrates 
a. Labeled Dextrans 
1 4 1 4 
C-dextran and C-dextran-sulfate were synthesized 
by the method of Marshall and Rabinowitz (132). Fifty 
l 4 
~Ci of C-glycine was incubated for 24 hours with 550 mg 
CNBr-activated dextran, yielding a label product with a 
specific activity of 50 cpm/~g. Dextran-sulfate was 
1 4 
labeled in a similar manner by adding 250 ~Ci C-gly-
cine to 600 mg of the CNBr-activated dextran and stirring 
1 4 
in the cold for 23 hours. The resultant C-labeled 
dextran-sulfate had a specific activity of 125 cpm/~g. 
3 
H-dextran was synthesized by the same procedure 
3 
using H-glycine. Two hundred and fifty ~Ci of tritiated 
glycine was added to 500 mg activated dextran and the 
reaction was allowed to proceed for one week. The result-
ant labeled dextran had a specific activity of 190 cpm/ug. 
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In preparing the various labeled dextrans, cold 
glycine was added at the end of each reaction to modify 
any of the free CNBr-activated sites which had not previ-
ously reacted with the label. The solutions were then 
dialyzed against distilled water in the cold to remove 
any unbound label. The samples were then lyophilized and 
refrigerated. 
Occasionally, the extent of labeling was monitored 
. 
during the course of the reaction by chromatographing 
samples of the reaction mixture on a column of Sephadex 
G-75. The extent of the reaction could be determined 
from the amount of label which co-chromatographed with 
the high molecular weight dextran. 
b. Iodination of Proteins 
Proteins were iodinated by three different tech-
niques. Hemoglobin and ovalbumin were iodinated by the 
method of Hunter and Greenwood (133) using chloramine-! 
1 2 5 
and Na I. The labeled proteins obtained had specific 
activities of less than 0.1 wCi/wg after purification on 
a Seuhadex G-75 column. 
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Human serum albumin was iodinated with lactopher-
oxidase by the method of J. Marchalonis (134) and puri-
fied by chromatography on G-75. It had a specific activ-
ity of 1.3 ~Ci/~g. 
All of the proteins, with the exception of HSA, 
were also labeled utilizing the Bio-Rad enzymobead kit. 
The reaction was stopped by filtering the reaction mix-
ture through an acrodisc to remove the bead-bound enzyme. 
1 2 5 
Unreacted I was subsequently removed by dialysis. The 
specific activities obtained varied from 0.1 to 2l.~Ci/~g 
depending on the urotein. Ovalbumin and hemoglobin la-
beled by this and the chloramine-T method gave similar re-
sults in all exneriments. 
The labeled proteins were refrigerated after puri-
fication and generally used within 3 days. Some were 
also frozen for later experiments. Media was added to the 
labeled protein solution just before use. The radio-activ-
ity of protein samples stored for any period of time was 
1 2 5 
corrected for the known decay rate of I. 
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2, Collection of Macrophages 
Eight-to-twelve-week-old male mice were injected 
intraperitoneally with 0.75 ml 4% thioglycollate media 
through a sterile filter to elicit stimulated macro-
phages. The cells were collected three days later by 
flushing the peritoneum with sterile Earls balanced salt 
solution through a syringe and collecting the lavage 
solution in a second syringe. Flushing of the peritoneum 
was repeated twice. The washings were combined in sterile 
centrifuge tubes and the cells collected by low speed 
centrifugation. The salt solution was then aspirated off 
and the cells resuspended in media. The pooled cells col-
lected from 3 to 8 mice were counted in a hemocytometer 
and aliquots containing 4 - 9 x 106 cells were plated on 
glass slides or plastic petri dishes. These numbers of 
cells were found to pinocytose sufficient labeled material 
to yield significant radioactivity when the cells were 
counted. Cell preparations were examined by phase con-
trast microscopy during initial studies and routinely with 
a cell culture microscooe. 
1 4 1 4 
Studies with C-dextran and C-dextran-sulfate 
were performed on glass coverslips. However, it was 
1 2 5 
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found that I-proteins incubated with glass coverslips 
adhered to the glass giving rise to high background 
counts. Plastic plates were used to minimize this non-
specific binding. Since fetal calf serum was found to 
compete with labeled proteins for the non-specific bind-
ing sites on the surface of the plastic plates, the up-
take media routinely contained 50% fetal calf serum. 
This level of fetal calf serum was also found to stimu-
late pinocytosis (110, 111). 
After the cells were dispersed onto glass cover-
slips or plastic tissue culture dishes, they were incu-
bated at 37°C for one to three hours. During this time, 
the macrophages adhered to the surface of the plates. 
The plates were then washed with sterile saline to remove 
any non-adherent cells and fresh media added. Cells used 
for an overnight labeling experiment were then exposed to 
media containing the labeled material for 12 to 20 hours 
at 37°C in 5% co2 . Alternatively, in some experiments 
50 
unlabeled media was added at this point and the cells sub-
sequently treated with label the next day. 
In some experiments, activated macrophages were 
elicited by injecting 0.5 ml Freund's complete adjuvant 
instead of thioglycollate media into the peritoneal cavity. 
The cells were collected and treated in the same manner as 
described for stimulated macrophages (those elicited by 
thioglycollate media) . 
3. Uptake of Labeled Material by Cells 
Media containing the radioactively labeled material 
was added to the cell cultures and uptake of the label 
was allowed to proceed for various oeriods of time. All 
cell cultures used in a given experiment were plated at 
the same time and with the same known number of macro-
phages. Fibroblast cultures were confluent monolayers 
when used. At the end of the uptake period, the labeled 
media was removed by aspiration and the cells washed five 
times with sterile saline. They were then incubated in 
media for 20 minutes and washed once more with saline. 
This orocedure was adopted to insure removal of any non-
specific label adsorbed to the surface of the olates. 
The efficacy of this procedure was tested with blank 
plates (plates without cells). 
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Cells cultured on coverslips were placed directly 
into test tubes or scintillation vials for counting. 
Cells cultured on plates were collected by sonifying 
them in 1 ml distilled water for 10 minutes to disrupt 
the cells. The disrupted cells were transferred to test 
tubes. The plates were then washed with an additional 
0.5 ml water and the washings added to the disrupted 
cells. The combined 1.5 mls obtained were then counted. 
examination of the plates with a tissue culture micro-
scope verified that no cells were left on the plate. 
This method was found to maximize the collection of cell-
associated radio-activity while minimizing the release of 
any labeled protein that might be bound non-specifically to 
the plate. This was confirmed by comparing various col-
lection procedures with both blank culture dishes and cul-
ture dishes containing cells. 
Blank plates or slides, those without cells. 'tvere 
run concurrently with those containing cells in order to 
determine what percentage of the label adsorbed to the 
surface of the support. Background counts, those from 
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non-specifically bound label as well as noise from the 
counting instruments, were substracted from the data. 
In most experiments, the blank represented less than 5% 
of the label collected. 
4. Degradation and Release of Pinocytosed 
Labeled Material by Cells 
The cell cultures were treated as described for the 
uptake experiments except that the cells were not collect-
ed after washing. Instead, fresh unlabeled media contain-
ing varying amounts of fetal calf serum was added to each 
plate and the rate of release of radioactivity into the 
fresh media was measured. Aliquots of media were removed 
at various times. These aliquots were then treated with 
an equal volume of 20% trichloroacetic acid - 1% phospho-
tungstic acid and the mixture incubated in an ice water 
bath for 30 minutes. The precipitated protein was removed 
by centrifugation. Both the supernatant and precipitate 
were collected and counted in a gamma counter. Media ali-
quots from experiments with the labeled dextrans were 
placed directly into scintillation vials without precipi-
tation. Rates of protein release were also measured in a 
second way. In these experiments, all the media was 
removed at each time point and replaced with fresh 
media, or only a small aliquot was removed and re-
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placed with an equal volume of fresh media. This was 
done in order to determine if nutrient depletion from 
the media or accumulation of metabolic end products in 
the media might have affected the degradation and re-
lease of labeled protein. These experiments also pro-
vide some information about whether any of the TCA-sol-
uble radioactivity formed could have been due to the 
degradation of intact labeled protein in the media by any 
extracellular proteases which might be present or re-
leased by the cells. The possibility of extracellular 
proteolysis was also checked by examining the effects of 
conditioned media on the labeled substrates. In these 
experiments, no evidence was obtained that the appear-
ance of TCA-soluble radioactivity could be due to the 
action of extracellular proteases on intact proteins 
which might have been regurgitated from the cell or ad-
sorbed to the surface of the culture dish. 
At the end of the release experiment, the cells 
54 
were collected in the manner described for the uptake 
experiments and counted. 
This method was developed so that all the data 
points from one experiment came from a single plate fol-
lowed over time and therefore the need to normalize the 
data from different plates is obviated. This is impor-
tant since estimates of cell density based on protein con-
tent are not sufficiently accurate when dealing with small 
numbers of cells, can occasionally lead to anomalously 
high values due to contamination of cells with even low 
levels of serum proteins normally present in the culture 
media, and can vary with cellular activity. One problem 
with this approach, however, is that the cell density in a 
given plate may change with time as a consequence of cell 
detachment and/or cell death. It was found that the amount 
of labeled protein collected from one plate before release 
agreed within the variability observed in duplicate uptake 
experiments (~ 15%) with the total amount of label associ-
ated with the cells undergoing release. In the cells 
undergoing release, the total amount of label is expressed 
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as the sum of the TCA-soluble radioactivity released, the 
TCA-insoluble radioactivity released, and the radioactiv-
ity remaining in the cell at the end of the release exper-
iment. Blanks, plates without cells, were also run in an 
identical manner. 
5. Analysis of Released Label 
Labeled material released into the media by cells 
was analyzed by gel chromatography utilizing Sephadex 
G-25 or G-50. The gels were poured into a column and 
equilibrated with at least three column volumes of buffer 
before use. 
The Sephadex G-25 column (1.6 x 10.5 em) was eluted 
with water:phenol:acetic acid (1:1:1) at 20 ml/hr. A 0.7 
ml sample of TCA-soluble label was applied to the column 
and 16 drop fractions collected to be counted in a gamma 
1 2 5 
counter. Monoiodotyrosine (MIT) and Na I were also 
run on the column in an identical manner. The MIT was 
detected in the fractions by the ninhydrin method of 
Moore & Stein (136). 
Media samples, as well as TCA-soluble material, 
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were chromatographed on a 1.6 x 60 em Sephadex G-50 
column with O.OSM phosphate buffer, pH 7.3, containing 
0.15 M NaCl at 30 ml/hour. The sample size for this 
column was 1.5 ml and 32 drop fractions were collected 
and counted. 
Uptake media, release media, and sonified cell 
samples were also analyzed by SDS gel electrophoresis 
according to the procedure of Weber and Osborn (137) . 
Samples were run for 23 hours on an 18% cross-
linked acrylamide gel. The gels were then sliced and 
each section counted. All samples contained bromphenol 
blue as a marker and the media samples also had phenol 
red. The solutions used in preparing the gels were as 
follows: 
Gel Buffer: 0.2 M Phosphate, pH 7.2 
0.2% SDS 
Sample Buffer: 0.01 M Phosphate, pH 7.2 
1% SDS 
1% 2-Mercaptoethanol 
Acrylamide B: 22.2 g Acrylamide/75 ml 
0.6 g Methyl Bisacrylamide 
Ammonium Persulfate: 15 mg/ml 
Running Gel: 15 ml Acrylamide B 
7.5 ml Gel Buffer 
1.0 ml Ammonium Persulfate 
0.045 ml TEMED 
Reservoir Buffer: 1 part Gel Buffer to 1 part 
distilled water 
The tubes were run at room temperature at a 
constant voltage of 4 mA/tube 
6. Miscellaneous 
a. Analvsis of Proteins Used 
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The proteins used for iodination were analyzed using 
the Corning cassette electrophoresis system with agarose 
film. The buffer was 0.05 M sodium barbital, pH 8.6, with 
0.035% EDTA. Samples, 0.002 ml of a 4 mg/ml solution. were 
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run for 40 minutes and the film stained for 20 minutes 
in an amido black solution followed by washing with 
acetic acid: methanol: water (1:7:2). The film was 
optically scanned in a Gelman scanner. 
The proteins were also analyzed by SDS disc gel 
electrophoresis utilizing the method of Weber and Osborn 
(137) as described previously, except that the samples 
were run on 7% gels. After electrophoresis, the proteins 
were fixed with acetic acid, stained with amido black, 
and washed with acetic acid: methanol: water (1:7:2). 
b. Analysis of Labeled Material 
Radioactively labeled dextran, dextran-sulfate, 
and protein were analyzed by column chromatography. 
1 4 
After labeling, C-Dextran was applied, in a 0.4 ml 
sample in acetate buffer, to a 15 ml Sephadex G-75 col-
umn and fractions collected. Aliquots of each fraction 
were added to 10 ml Bray's solution and counted. The 
hexose content of each fraction was determined with 
1 4 
phenol-sulfuric acid (138). C-Dextran-sulfate was 
analyzed in a similar manner. 
Iodinated hemoglobin was also analyzed by chroma-
tography. In this procedure, Sephadex G-75 equilibrated 
in acetate buffer was used. The fractions obtained were 
analyzed for both radioactivity and protein. Twenty-
five percent of the label was found associated with 
the protein peak. 
1 2 5 
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The I-BSA obtained commercially was subjected to 
affinity chromatography on an Affi-gel blue Sepharose col-
1 2 5 
urnn which specifically binds native albumin. I-BSA 
was added to the column in 0.02 M phosphate buffer, pH 
7.1, and the column washed with this buffer until no more 
1 2 5 
radioactivity eluted. The bound I-BSA was then elu-
ted from the gel with phosphate buffer containing 1.4 M 
1 2 5 
NaCl. Samples of affinity purified I-BSA were then 
dialyzed before use against water to remove salts. 
Other proteins used in cellular uptake and degra-
dation experiments were also analyzed by SDS gel elec-
trophoresis on 7% gels essentially as described previ-
ously. 
c. Denaturation of Protein 
1 2 5 
I-BSA \vas denatured by immersing a solution con-
taining 0.2 mg/ml in a boiling water bath for 10 minutes. 
Media was added after the solution cooled and this was 
filtered before use. The labeled heat-treated protein 
remained soluble at these concentrations. The denatur-
ation of the labeled BSA was verified by chromatography 
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on an Affi-gel blue affinity column. 
B-Galactosidase was denatured by freezing and thaw-
1 2 5 
ing after labeling with I. The degree of denatur-
ation was tested by assaying for activity (139). 
d. Protein Degradation by Cell Lysates 
Stimulated macrophages were plated and allowed to 
incubate overnight before use. Cell lysates were col-
lected from the plates by sanification for 10 minutes in 
1 ml 0.1 M acetate buffer, pH 5. 
Degradation of labeled protein by these cell 
lysates was studied by two techniques. In the first, 
labeled protein was added to the cell lysate to give a 
final concentration of 9 x 105 cpm/ml. In the second 
7 125 
method, 10 cpm/ml I-protein was added to the cell 
cultures for the overnight incubation and the cells al-
lowed to pinocytose the label. The cells were washed as 
described previously and the lysates prepared. For both 
techniques, aliquots of the lysates were removed at vari-
ous times, treated with an equal volume of 20% TCA-1% 
phosphotungstic acid, and analyzed as described previous-
ly for TCA-soluble and TCA-insoluble radioactivity. 
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e. Partial Purification of Cathepsin B1 
Cathepsin B1 was partially purified from mouse 
liver by the method of Bajkowski and Frankfater (140}, 
The liver was homogenized and stirred in 1% NaCl, 2% 
N-butanol, 10-~ EDTA, 0.2% Triton X-100, pH 6.1, for 
one hour and centrifuged to remove the precipitate. 
The pH of the supernatant was adjusted to 4.4 with HAc 
and spun again at 17,000 rpm. The supernatent was mixed 
with 1.3 volumes acetone and again centrifuged as before. 
The precipitate was dissolved in 0.025M NaAc, pH5.1, with 
0.1 M NaCl and 10-3M EDTA and dialyzed overnight against 
this same buffer. The sample is then further purified by 
chromatography on Sephadex G-150. 
f. Enzyme Assays 
1. Cathepsin B 
Cathepsin B activity was assayed by the method of 
Bajkowski and Frankfater (140) using CBZ-glycine-nitro-
phenyl ester as the substrate. The enzyme is incubated 
for 15 minutes with dithiothreotol in 0.025M NaAc, pH5.1 
with 10- 3M EDTA before the addition of substrate. 
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2. Pauain 
Papain was assayed by the same method as Cathepsin 
B. 
3. Trypsin 
Trypsin was assayed utilizing tosyl-arginine-
methyl ester (TAME) as a substrate (160). The buffer 
used was O.SM Tris-HCl, pH 8.1. 
CHAPTER III 
RESULTS 
A. Characterization of Labeled Substrates 
Reaction mixtures containing CNBr activated dextran 
or dextran-sulfate and radioactively labeled glycine were 
analyzed by Sephadex G-25 chromatography at varying times 
during the reaction to monitor the extent of the coupling. 
Figure 4 shows the elution profile of the labeling solu-
tion of dextran-sulfate after 24 hours demonstrating that 
1 4 
C activity is associated with both high and low molec-
ular weight species. Similar analysis of aliquots of the 
labeling solution after 1, 2, and 13.5 hours demonstrated 
1 4 
a progressive increase in the percentage of C activity 
associated with the high molecular weight peak. The per-
cent of label in the high molecular weight fraction in-
creased from 15% after 1 hour to 27% and 85% after 2 
hours and 13.5 hours respectively. Similar results were 
1 4 
also obtained for labeling experiments with C-glycine 
3 
or H-glycine and dextran. Proteins used in the prepa-
1 2 5 
ration of I-labeled substrates were analyzed prior to 
labeling by electrophoresis with the Corning cassette 
electrophoresis system to determine their purity. Most 
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Figure 4. 14 Chromatography of the C-Dextran-sulfate 
labeling solution on Sephadex G25 in 0.5M acetate 
buffer, pH 5.0. Aliquots (0.1 ml) of each 0.3 ml 
fraction were added to 10 mls Bray's solution to be 
counted in the scintillation counter. The reaction 
was allowed to proceed 24 hours before analysis. 
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proteins yielded a single major band. Ovalbumin and 
catalase preparations appeared to contain minor impu-
rities which represented no more than 20% of the total 
protein. Enolase showed two major bands whose propor-
tions varied with protein concentration and which prob-
ably represented a monomer-dimer equilibrium. Similar 
results were obtained for these proteins by SDS disc gel 
electrophoresis. Each lot of protein obtained was ana-
lyzed before use. 
1 2 5 
After labeling with I, the protein substrates 
were further analyzed. Figure 5 is an elution profile 
1 2 5 
for I labeled hemoglobin obtained with a Seuhadex 
G-75 column (1.6 x 30 em). It shows about 10% of the 
radioactivity associated with the hemoglobin peak. From 
the areas under the peak and knowledge of the total pro-
tein, the specific activity of the labeled hemoglobin 
could be estimated. 
Other proteins, after labeling, were precipitated 
with 10% TCA on ice and the amount of label associated 
with the TCA-insoluble fraction was measured. These 
results were then used to estimate the specific activity 
of these proteins. The results summarized in Table 1 
list the proteins labeled, the technique used, and the 
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Figure 5. Chromatography of the I-hemoglobin 
labeling solution on Sephadex G75 in 0.5 M acetate 
buffer, pH 5.0. Aliquots of each 1.8 ml fraction 
were removed for counting. 
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TABLE 1 
LABELED PROTEINS USED 
Protein Labeling Technique 1JCih.1g 
Arginase (Prep. 1) Enzymobead 0.72 
Arginase (Prep. 2) Enzymobead 0.56 
Catalase Enzymobead 0.17 
Cytochrome c (Prep. 1) Enzymobead 1.17 
Cyrochrome c (Prep. 2) Enzymobead 1. 83 
Enolase Enzymobead 0.30 
8-Galactosidase Enzymobead 4.30 
Hemoglobin Enzymobead 1. 63 
HSA (Prep. 1) Lactoperoxidase 1. 30 
HSA (Prep. 2) Lactoperoxidase 0.73 
Ovalbumin (Prep. 1) Chloramine T <0.001 
Ovalbumin (Prep. 2) Enzymobead 0.43 
Phos~horylase b (Prep. 1) Enzymobead 1.11 
Phosphorylase b (Prep. 2) Enzymobead 2.10 
Ribonuclease (Prep. 1) Enzymobead 1. 90 
Ribonuclease (Prep. 2) Enzymobead 0.04 
Thyroglobulin Enzymobead 1. 27 
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specific activities obtained. 
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I-BSA obtained commercially was characterized 
by affinity chromatography on an Affi-gel blue column. 
In this chromatographic support, Cibacron Blue F3GA, a 
reactive blue dye, is covalently linked to an insoluble 
agarose matrix. The resulting gel will bind albumin and 
other proteins which contain an organic anion binding 
site. With one batch of albumin, 3 separate determina-
tions yielded 81%, 79%, and 83% of the total radioactiv-
ity bound to the affinity column. A similar analysis of 
1 2 5 
a second batch indicated 80% of the total I activity 
bound to the affinity column. The bound fractions were 
eluted as described previously. 
B. Uptake of Nondigestible Materials 
The uptake of nondigestible material by cultured 
macrophages was first investigated. Cells were allowed to 
3 1 4 1 4 
pinocytose H- or C-dextran or C-dextran-sulfate for 
varying periods of time. The cells were then washed and 
cell samples collected. In order to normalize the data 
for differences in the amounts and s~ecific activities of 
the labeled materials and differences in the quantities of 
cells used in the various experiments, the results are 
expressed as microliters of medium ingested per 106 cells 
plated (141) . 
This value was calculated by the formula: 
6 f.ll/10 Cells = 
1 to 
Amount of Cell 'Concentration of 
Associated Radioactivitv in 
Radioactivity/ Medium · 
Number of Cells Plated/106 
The uptake of C-dextran-sulfate, which is known to 
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cause increased pinocytotic vesicle formation (142), is 
shown in Figure 6. Our data for the uptake of labeled 
dextran is similar except that it occurs at only about 
1/20 the rate of uptake of dextran-sulfate. 
C. Uptake of Digestible Substrates 
1 2 5 
I-BSA uptake by cells was also studied (Figure 
7). In this case, the accumulation was less than that 
for nondigestible materials; possibly due to the ongoing 
1 2 5 
degradation of I-BSA and release of free label into 
1 2 5 
the media. The rate of accumulation of I-BSA by the 
cells was similar in the presence of dextran and markedly 
increased in the presence of dextran-sulfate, which 
causes increased pinocytotic vesicle formation (142). 
The effect of different concentrations of labeled 
BSA in the media on the amount taken up over a 12 hour 
labeling period was also investigated (Table 2) . These 
experiments were performed with two different batches of 
1 4 
Figure 6. Untake of C-dextran-sulfate by 
macrophages. Uptake was performed in 50% FCS with 
5 mg/ml dextran-sulfate (160,000 cpm/ml) for 
varying time periods. Each time point represents 
6 a separate plate with 3 x 10 rnacrophages. 
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Figure 7. Uptake of I-BSA by macrophages. Uptake 
was performed in media with 50% FCS with 1 x 107 
cpm/ml in the absence (*) and the presence of 1 mg/ml 
dextran-sulfate ( o ) . Each point represents a single 
plate with 2.6 x 106 cells. 
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TABLE 2 
125 125 a 
I-BSA Uptake With Different Concentrations of I-BSA in the Uptake Media 
a 
cpm/ml x 106 
1 2 5 
I-BSA 
1.7 
6.7 
15.0 
4.0 
6.0 
12.0 
Macrophage 
Preparation 
lc 
lc 
lc 
2d 
2d 
2d 
Cell Associated 
Radioactivity 
(cpm) 
516,545 
2964,1924-
5755,4851 
557,622 
783,948 
1419,1737 -
Uptake was performed in media with 50% FCS for 12 hours. 
b 
Average of 2 determinations 
c 6 
Number of cells plated was 7.9 x 10 
d 6 
Number of cells plated was 5.3 x 10 
]11/106 Cells 
Platedb 
0.04 
0.05 
0.04 
0.03 
0.03 
0.03 
....... 
0\ 
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macrophages as indicated. The rate of uptake was seen 
to vary somewhat between the two preparations of cells. 
In general, results of many such experiments show a 
one to two fold variation in U?take rates between dif-
ferent batches of macrophages. From the results in 
1 2 5 
Table 2, it can be seen that the cpm of I-BSA accu-
mulated by the cells was dependent on the initial 
cpm/ml in the media. When the data is normalized for 
the different cpm/ml media and cell numbers by expres-
sing the results as ~ls of media ingested per 106 cells, 
it can be seen that the amount of labeled media ingested 
is relatively constant. If the uptake were receptor 
mediated, one would expect that the calculated volume of 
media taken up per 106 cells would appear to decrease with 
increasing concentration of labeled protein in the media. 
Therefore, if receptors are involved in BSA uptake, they 
could not have been saturated with BSA under these condi-
tions. This might be expected in view of the large quan-
tities of extraneous proteins present in the uptake media 
arising from the presence of fetal calf serum (50}. Con-
sistent with this finding is the observation that excess 
cold BSA does not inhibit the uptake of labeled BSA 
(Table 3). These results also eliminate the possibility 
78 
TABLE 3 
1 2 5 
I-BSA Uptake in the Presence of Varying Amounts of 
Cold BSA a 
Cold BSA Added 
(mg/ml) 
a 
0 
0.1 
1.0 
Cell Associated 
Radioactivity 
(cpm) 
15,420;16,542 
12,314;17,686 
11,699;19,888 
lll/106 Cellsb 
0.023 
0.021 
0.023 
Uptake was performed in media containing no FCS for 18 
7 1 2 5 
hours with 1.4 x 10 cpm/ml I-BSA (O.Olmg/ml). 
b 
Average of 2 determinations 
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that the cell associated radioactivity represents pro-
tein non-specifically bound to the surface of cells or 
the culture dishes. 
Similar results have been obtained in uptake 
studies of labeled albumin macrophages by others (104). 
Results obtained for uptake of other proteins in this 
work are generally similar. 
1 2 5 
Uptake experiments were also performed with I-BSA 
before and after dialysis in order to verify that uptake 
1 2 5 
was not due to the accumulation of free I by the cells 
1 2 5 
or the binding of free I to the culture plates. The 
1 2 5 
results for the dialyzed I-BSA were similar to those 
1 2 5 
for I-BSA before dialysis (Table 4) . 
Blank plates, those with no cells added, treated in 
the same manner as the plates with cells, took uo less 
than 10% of the amount of label as did plates containing 
cells, further indicating that the apparent accumulation 
of radioactivity by the cells was not due to nonspecific 
binding of label to the plates. 
The.simultaneous addition of lysosomal protease in-
1 2 5 
hibitors with the I-BSA caused an increased overnight 
accumulation of radioactive label (Table 5) . This could 
80 
TABLE 4 
1 2 5 1 2 5 
1-BSAa 1-BSA Uotake With Nondialyzed and Dialyzed 
SamEle % TCA Soluble lll/106 Cellsb 
Nondialyzed 7.5 0.018c + 0.004 
-
Dialyzed 0.3 0.016d + 0.001 
aUptake was performed in media with 50% FCS for 16 
hours. 
bResults expressed as mean ± standard deviation 
cAverage of 5 determinations 
d Average of 4 determinations 
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TABLE 5 
1 2 5 
I-BSA Uptake in the Presence of Inhibitorsa 
Inhibitor 
None 
Anti pain 
Leupeptin 
Pepstatin 
Chloroquine 
Inhibitor Concentration 
in Media (mg/ml) 
0.29 
0.29 
0.06 
0.05 
Volume of Media 
in Cells 
lll/106 Cells 
0.013 + .006b 
0.050 + .017b, 
-
0.073 + .012b, 
-
0.040 + .OlOb, 
-
0.060 + .014e 
-
aUptake was performed in media with 50% FCS for 18 hours. 
b 3 D . . eterm~nat~ons. Mean + standard deviation 
cDifference from control statistically significant, 
p< .05. 
duiffere~ce from control statistically significant, 
p < . 01. 
eAverage of two determinations 
+ 
- .; 2 L X 
n - 1 .p < .1. 
c 
d 
c 
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be due to decreased degradation of the pinocytosed la-
beled protein by the cells. 
The effect of alterations in protein structure on 
the overnight accumulation of labeled BSA was also inves-
tigated. Binding and nonbinding fractions of Affi-gel 
blue purified BSA were found to be accumulated by macro-
phages at comparable rates (Table 6). In contrast, 
1 2 5 
I-BSA denatured by boiling, which demonstrated a de-
creased binding to the Affi-gel blue column, showed an 
increased accumulation uptake after an overnight incuba-
tion with cells. 
The uptake of other iodinated proteins by macro-
phages following overnight incubation is shown in Table 
7. The value reported for ovalbumin was obtained both_ 
at ovalbumin concentrations of 1.1 ug/ml and 45 ug/ml, 
The observation that the calculated volume of media is 
indenendent of the concentration of label in the media is 
evidence that uptake of this protein was also non-re.cep-
tor mediated. The uptake of 13-galactosidase denatured by 
freezing was less than that of the native form after an 
overnight incubation with cells, This is in contrast to 
the results obtained with native and denatured BSA, How 
ever, it will subsequently be shown that the denatured 
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TABLE 6 
125 a 
Effect of Protein Conformation on the Uptake of I-BSA 
Affi-Gel Blue Column Samples 
Sample 
Before column 
Binding fraction 
Nonbinding fraction 
1 2 5 
Radioactivity in 
Uptake Media6 (cpm/ml x 10 ) 
3.9 
3.5 
3.5 
Boiled I-BSA Samples 
Sample cpm/ml X 106 
Uptake Media 
Before boiling 6.3 
After boiling 1.5 
Calculated Volume 
of Media Taken Uo 
~1/106 Cellsb ~ 
0.020 + .006c 
0.023d 
0.018d 
0.018 + 0.002c 
0.087 + 0.012e 
a Uptake was performed in media with 50% FCS for 24 hours. 
b 
Values given as the mean + standard deviation 
c 
Average of 3 determinations 
d 1 . 1 d ~ . Va ue represents a s~ng e ·eterm~nat~on 
e 
Average of 5 determinations. Difference statistically 
significant (p < .0005). 
TABLE 7 
Uptake of 
12s a 
I-Labeled Proteins 
Protein 
Ribonuclease 
Arginase 
Enolase 
Ovalbtm1in 
Catalase 
BSA 
Phosphorylase b 
B-Galactosidase 
Thyroglobulin 
0.043 + 0.015c 
0.034 + 0.015d 
0.078 (O.OS,O.lO)e 
f 0.263 + 0.010 
0.049 + 0.016f 
0.030 + 0.012g 
0.220 (0.340,0.100)e 
0.090 (0.091,0.089)e 
0.396 + O.llOf 
84 
aUptake was performed in media with 50% FCS for 18 to 
24 hours. 
bValues expressed as the mean + standard deviation 
cAverage of 4 determinations 
dAverage of 5 determinations 
eAverage of 2 determinations. Individual values in 
parentheses 
fAverage of 3 determinations 
gAverage of 17 determinations 
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form of S-galactosidase is degraded at a very much great-
er rate than the native form. Since the amount accumu-
lated probably re~resents a steady state between uptake 
and degradation, one would expect less of the denatured 
form to accumulate. 
D. Release of Nondigestible Materials 
The release of labeled dextran-sulfate into the 
media from cultured macrophages was studied in order to 
determine if nondigestible macromolecules could escape 
from the cells and, if so, to quantitate the extent of 
this release (Figure 8). This experiment was performed 
by counting both the cells and the media at various 
times during the release. It can be seen that there ap-
pears to be a rapid release of radioactivity within the 
first 5 hours, followed by a very slow loss of label 
from the cells (less than 0.5% per hour). Approximately 
20% of the label was lost in the initial phase. Similar 
results have been obtained in studies of the u~take and 
1 2 5 1 2 8 
release of I-PVP and insoluble Au labeled gold 
salts (105). This has been attributed to regurgitation 
of the contents of some of the pinocytic and phagocytic 
vesicles by the ma~rophages rather than to cell detach-
ment and/or cell death. 
1 4 
Figure 8. Release of C-activity from macrophages 
that had pinocytosed 1 mg/ml dextran-sulfate 
(32,000 cpm/ml) for 24 hours. The samples were then 
washed and fresh media added. Uptake and release 
media contained 30% FCS. Each point represents a 
single plate that was washed, the cells scraped off 
the plates in 0.2 mls water, and Bray's solution 
added to the cell suspension for scintillation 
counting. 
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E. Degradation of Protein Substrates 
The release of label from cells containing digest-
1 2 5 
ible I-labeled protein was also studied. Figure 9 
illustrates the time course of the appearance of radio-
1 2 5 
activity in the media after uptake of I-BSA for 15 
hours. As with dextran-sulfate, the release of TCA in-
soluble radioactivity is not linear. Approximately 70% 
of the released TCA insoluble radioactivity appears in 
the initial rapid phase. During the slow phase, less 
than 0.1% per hour of the total label within the cell is 
released as TCA insoluble radioactivity. The similarity 
between this result and that obtained with labeled dex-
tran-sulfate suggests that the release of TCA insoluble 
radioactivity represents regurgitation of intact protein. 
The release of TCA soluble radioactivity also appears not 
to be linear. In this case, however, the release of TCA 
soluble label continues well after the release of insol-
uble label has reached a plateau. Similar results were 
obtained with the other proteins studied. 
One object of the experiments, whose results are 
shown in Figure 9, is to measure the rate of degradation 
of pinocytosed labeled proteins, One method is to plot 
the log of the percent of radioactively labeled protein 
1 2 5 
Figure 9. Release of !-activity in the media from 
macrophages incubated with 1 x 107 cpm/ml 
1 2 5 
I-BSA in 50% FCS for 15 hours. Media samples 
(1% FCS) were removed from a single plate at various 
time points and precipitated with an equal volume of 
20% TCA - 1% phosphotungstic acid before counting. 
The cells were counted at the end of the experiment. 
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remaining in the cell vs time. The percent cpm remain-
ing could be obtained with the help of the following 
relationship: 
%cpm Total cpm taken up - cpm released 
remaining = x 100 
Total cpm taken up 
91 
However, if the percent cpm remaining is plotted vs time 
it yields estimates for the rate of protein degradation 
which are too large because this equation fails to ac-
count for label which is released through regurgitation 
of intact or partially degraded protein. Alternatively, 
we could express percent cpm remaining as being equal to: 
Total cpm taken up - TCA soluble cpm released 
------------------------------------------------X 100. 
Total cpm taken up 
However, this underestimates rates of protein degradation 
by overestimating the amount of label remaining in the 
cell since the loss of TCA insoluble radioactivity 
through regurgitation is not counted. Clearly, therefore, 
some method is needed to correct for the loss of TCA in-
soluble label from the cells with time. An exact and rig-
orous correction is not possible because the mechanism by 
which the TCA insoluble radioactivity is released is un-
known. 
92 
As a first approximation we have assumed that the 
TCA insoluble radioactivity released represents labeled 
substrate which is regurgitated prior to any significant 
exposure to the hydrolytic enzymes in the cell. Accord-
ingly, we have subtracted the TCA insoluble radioactivity 
released from the total radioactivity taken up by the 
cell. The amount of labeled protein taken up which is 
available for degradation is then expressed as being 
equal to the sum of the TCA soluble radioactivity re-
leased and the radioactivity remaining in the cell at the 
end of the release experiment as shown below: 
Total cpm avail-
able for hydrol-
ysis 
= Total TCA sol- + TCA cpm remaining at 
uble cpm re- end of release 
leased period 
The percent radioactivity remaining in the cell at any 
time, t, is thus given by: 
~ cpm remain- = Total cpm - TCA soluble cpm releasedt 
~ngt available 
X 100 
-------------------------------------Total cpm available 
Figure 10 illustrates the results in Figure 9 replotted 
according to this equation (closed circles). The open 
circles show the same data uncorrected for the release 
of TCA insoluble label. In the latter case, the initial 
rate of release of label (initial slope) appears more 
93 
Figure 10. A replotting of Figure 9 using the equa-
tion (cpmt-cpmr) /cpmt = % cpm remaining at time t. 
The log of this value is plotted versus the time in 
hours. The crosses represent the incorrected data 
plotted in this fashion. The squares show the same 
data corrected for TCA insoluble label. 
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rapid because of regurgitation of TCA insoluble label 
from the cells. However, the final rates of release 
are more nearly similar for both curves since by 20 
hours the rate of loss of label is due primarily to pro-
tein degradation in both cases. 
In order to verify that the TCA insoluble radio-
activity released by the cells into the media represented 
larger molecular weight species, and that TCA precipita-
tion was effective in removing these, media samples were 
analyzed by Sephadex chromatography before and after pre-
cipitation with TCA. Figure 11 shows the Sephadex G-50 
elution profiles for the release media obtained on incu-
1 2 5 
bating I-BSA laden fibroblasts in unlabeled media for 
24 hours. Similar results were also obtained with re-
1 2 5 
lease media from I-BSA laden macrophages. The elution 
profile for the media prior to TCA precipitation shows the 
presence of both large and small molecular weight species. 
The small molecular weight peak was made up of at least 3 
components. This is in agreement with results obtained by 
others (104, 126-128) which demonstrated the release of 
labeled monoiodotyrosine, diiodotyrosine, glycyliodotyro-
1 2 5 
sine and free I from cells but no species of inter-
mediate molecular weight (300 to 10,000). TCA precipita-
tion of the media removed the high molecular weight 
Figure 11. Chromatography of media (0), TCA sol-
uble media(+), and cell extracts (D) from a 
1 2 5 
I-BSA release experiment where fibroblasts were 
allowed to take up label overnight. Each 1.5 ml 
fraction was counted directly in a gamma counter. 
The Sephadex G50 column was eluted with 0.05M phos-
phate, 0.15 M NaCl, pH 7.3 at 24 ml/hour. The column 
was previously calibrated and Vo corresponded to 
fraction 12 while Vi was fraction 42. 
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material. Similar elution profiles were obtained for 
1 2 5 
media samples from macrophages fed I-S-galactosidase 
125 
and !-phosphorylase b. In each case, the high molec-
ular weight component eluted in the void volume of the 
column indicating a molecular weight greater than 30,000. 
SDS electrophoresis of media yielded similar results; 
only large and small iodinated molecular weight species 
present in the release media. In addition, the TCA in-
soluble material was shown to be of the same size as the 
labeled protein before addition to the media. 
125 
The degradation and release of I activity by 
1 2 5 
cells fed I-BSA appeared to be nonlinear when plotted 
on semilog paper (Figure 10) . There are a number of 
possible explanations for this behavior. Some of these 
are: 
1 2 5 
1) The I-BSA preparations used are heterogene-
ous, containing impurities which. are degraded 
at rates which differ from that of authentic 
1 2 5 
I-BSA. 
1 2 5 
2) The I-BSA preparations contain denatured 
forms of BSA which are deg~aded at different 
rates than native BSA. 
1 2 5 
3) The I-BSA preparations are relatively 
homogeneous, but the physical and chemical 
environments of the individual labeled 
amino acid residues in the protein are 
heterogeneous. 
4) All the labeled amino acid residues in the 
protein are equally susceptible to release 
by cellular proteases but the cells them-
selves are heterogeneous with some having 
a greater hydrolytic capacity than others. 
99 
5) All the cells are homogeneous but each cell 
contains a heterogeneous population of lyse-
somes, which remain segregated during the 
release experiment, and which have different 
levels of various hydrolases. 
6) The rate of release becomes progressively 
slower with time because of progressive 
changes which occur in the media during the 
course of release. 
7) Some combination of the above explanations. 
100 
To distinguish between some of these possible exnla-
nations, release experiments were performed utilizing a 
variety of labeled protein substrates, different batches 
of macrophages, different cell types, and a different ex-
perimental procedure. The results of these experiments, 
which will be described below, tend to support explana-
tion 3 for the biphasic appearance of the protein degra-
dation curves. 
To determine if the nonlinear curves for the re-
12s 
lease of label from I-BSA laden macrophages is due to 
the presence of labeled impurities or denatured forms of 
1 2 s 
the protein, commercial preparations of I-BSA were 
purified by affinity chromatography on Affi-gel blue. 
This gel binds albumin through an anion binding site on 
the protein and denaturation of the protein would presum-
ably lead to the destruction of this site. Both the bind-
ing and non-binding fractions of these labeled BSA prepa-
rations yielded nonlinear release curves which were simi-
lar to each other and to those obtained with commercial 
preparations before purification. Curves obtained with 
1 2 5 
heat treated I-BSA show some initial enhancement in 
the rate of degradation of the pinocytosed protein sub-
strate but are still remarkably similar to curves for 
the native protein (Figure 12). These results argue 
against explanations 1 and 2. 
10:L 
To determine if the nonlinear curves were due to 
the presence of heterogeneity in the population of macro-
phages used in these studies, the experiments were re-
peated with a number of different batches of stimulated 
macrophages (thioglycolate media induced macrophages), 
with activated macrophages (Freunds adjuvant induced 
macrophages), and with baby hampster kidney fibroblasts. 
All preparations of stimulated macrophages gave similar 
time curves. In addition, while it was observed that 
activated macrophages, stimulated macrophages, and fibro-
blasts degraded albumin at slightly different rates, the 
shapes of the curves were similar suggesting that the 
curvature was a property of the protein and not the cell 
preparations. This conclusion was reinforced by results 
obtained for the degradation of other protein substrates, 
Figures 13 through 23 show the data obtained for protein 
substrated. The lines were generated by linear regression 
of the data points. In many cases, the early time points 
appeared to fall above the line while the intermediate 
time points appeared to be below the line. In addition, 
in almost all cases, the least squares line did not 
1 2 5 
Figure 12. Release of TCA soluble !-activity 
from macrophages incubated with 6 x 106 cpm/ml 
1 2 5 
heat treated I-BSA for 22 hours. Each point 
represents the mean ± standard deviation. The 
least squares line is indicated. Correlation 
coefficient= 0.977. 
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Figure 13. Release of TCA soluble radioactivity from 
125 
macrophages incubated overnight with !-cytochrome c. 
The points indicate the mean ± standard deviation for 
6 experiments. Cell preparations used were numbers 7, 
8, 10, and 11. The least squares line is indicated. 
Correlation coefficient = 0.838. 
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Figure 14. Release of TCA soluble radioactivity from 
1 2 5 
macrophages incubated overnight with !-ribonuclease. 
The points indicate the mean ! standard deviation for 
3 experiments. Cell preparations used were numbers 12, 
17, and 18. The least squares line is indicated. Cor-
relation coefficient = 0.859. 
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Figure 15. Release of TCA soluble radioactivity from 
1 2 5 
macrophages incubated overnight with !-hemoglobin. 
The points indicate the mean ± standard deviation for 
6 experiments. Cell preparations used were numbers 
9, 10, and 11. The least squares line is indicated. 
Correlation coefficient = 0.955. 
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Figure 16. Release of TCA soluble radioactivity from 
1 2 5 
macrophages incubated overnight with !-arginase. 
The points indicate the mean ~ standard deviation for 
7 experiments. Cell preparations used were numbers 7, 
110 
10, 11, 17, and 18. The least squares line is indicated. 
Correlation coefficient = 0.959. 
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Figure 17. Release of TCA soluble radioactivity from 
l 2 5 
macrophages incubated overnight with I-enolase. The 
points indicate the average± variation for 2 experiments. 
Cell preparations used were numbers 17 and 18. The least 
squares line is indicated. Correlation coefficient 
= 0.802. 
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Figure 18. Release of TCA soluble radioactivity from 
125 
macrophages incubated overnight with !-ovalbumin. 
The points indicate the mean ± standard deviation for 
4 experiments. Cell preparations used were numbers 5, 
10, and 11. The least squares line is indicated. Cor-
relation coefficient = 0.861. 
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Figure 19. Release of TCA soluble radioactivity from 
1 2 5 
macrophages incubated overnight with !-catalase. 
The points indicate the mean + standard deviation for 
3 experiments. Cell preparation used was number 13. 
The least squares line is indicated. Correlation 
coefficient = 0.958. 
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Figure 20. Release of TCA soluble radioactivity from 
1 2 5 
macrophages incubated overnight with I-BSA. The 
points indicate the mean ± standard deviation for 23 
experiments. Cell preparations used were numbers 1, 
2, 6, 12, 14, 15, 16, 18, 19, and 20. The least 
squares line is indicated. Correlation coefficient 
= 0.937. 
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Figure 21. Release of TCA soluble radioactivity from 
125 
macrophages incubated overnight with !-phosphorylase 
b. The points indicate the mean ± the standard deviation 
for 4 experiments. Cell preparations used were numbers 
7 and 17. The least squares line is indicated. Corre-
lation coefficient = 0.872. 
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Figure 22. Release of TCA soluble radioactivity from 
macrophages incubated overnight with 1251-S-galactosi-
dase. The points indicate the average ±variation for 
2 samples. Cell preparation used was number 13. The 
least squares line is indicated. Correlation coeffi-
cient= 0.937. 
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Figure 23. Release of TCA soluble radioactivity from 
macrophages incubated overnight with 1251-thyroglo-
bulin. The points indicate the average ± variability 
for 2 experiments. Cell preparations used were numbers 
12 and 18. The least squares line is indicated. Corre-
lation coefficient = 0.985. 
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extrapolate to zero on theY axis. The results of the 
linear regression calculations are shown in Table 8. 
For each protein, the degradation rate constant, k 
(hr-1), was determined from the slope of the log plots 
of cpm remaining vs time. In an effort to judge the 
contribution of the slower phase of the curves to the 
total release of soluble label, least squares lines 
drawn through later time points (> 8 hours) were ex-
trapolated to time zero. Table 8 also contains the per-
cent of total label released during the latter stage of 
the degradation reactions for the proteins studied. 
With the apparent exception of BSA, and thyroglobulin, 
the proportion of label released at the slower rate 
seems to increase with the increasing size of the pro-
tein. 
If the fast and slow phases of the release curves 
were due to the contributions of two distinct populations 
of macrophages, one would have to postulate that the low 
molecular weight protein substrate was preferentially 
taken up by cells with a high hydrolytic activity, where-
as high molecular weight substrates preferentially accu-
mulated in cells with low levels of hydrolases. No 
obvious mechanism is known at present whereby this could 
127 
TABLE 8 
Calculated Rate Constants and Y - Intercepts 
Apparent First Ordera 
Protein Rate Constant (X 103) Y-Interceptb 
Cytochrome c 28.3 + 2.8 - .183 (83) 
Ribonuclease 22.3 + 3.7 - .333 (72) 
Hemoglobin 33.5 + 1.5 - .134 (87) 
Arginase 18.5 + 0.8 - .136 (87) 
Enolase 14.3 + 2.7 - .141 (87) 
Ovalbumin 12.6 + 1.6 - .185 (83) 
Catalase 11.0 + 0.8 - .110 (90) 
BSA 27.3 + 0.8 - .236 (79) 
Phosphorylase b 11.0 + 1.2 - .029 (97) 
13-Galactosidase 1.2 + 0.1 
-
.039 (96) 
Thyroglobulin 17.5 + 0.9 - .135 (87) 
aCa1culated from all data points. Value given is mean 
+standard deviation. Units are h-1 . 
bCalculated from all data points after 8 hours. 
The value in the parentheses is the percentage of label 
released from the cells in the slower phase. 
128 
occur. These results obtained with different protein 
substrates also tend to eliminate explanation 5 since 
no mechanism has been reported which could account for 
segregation of large and small pinocytosed proteins 
into different populations of lysosomes. Finally, the 
following experiment was performed to determine if the 
nonlinear protein degradation curves were due to accu-
mulation of inhibitory metabolites in the media, as 
macrophages are known to secrete inhibitors (159), or 
depletion of some essential factor or nutrient from the 
1 2 5 
media. Cells loaded with I-BSA as described previous-
ly were allowed to release label as before, except at 
each time point all the media was removed and replaced 
with fresh media at 37° C. The results obtained did not 
differ significantly from those of previous experiments. 
This experimental result also argued against the possibil-
ity that some of the TCA soluble radioactivity resulted 
from the action of extracellular proteases on any intact 
1 2 5 
I-BSA present in the media. In order to more defini-
tively eliminate this possibility, macrophages at a den-
sity of 4 x 106 cells added per plate were incubated for 
12 hours in media. At the end of this incubation, the 
conditioned media was transferred to a cell free culture 
1'29 
1 2 5 6 
plate and I-BSA (10 cpm/ml) added. There was no ob-
servable increase in the TCA soluble radioactivity even 
after 18 hours of incubation at 37° C. 
F. Effect of Protein Size on Degradation Rate 
The results of the protein degradation experiments 
described in Figures 13 - 23 were performed with iodinated 
protein substrates of varying molecular weight. In gen-
eral, it was found that proteins with smaller subunit mo-
lecular weights were degraded more rapidly than those with 
larger subunits. This is shown graphically in Figure 24 
where cpm remaining/cpm total at 35 hours is plotted 
against the log (subunit molecular weight). 
The data was analyzed by computer and linear regres-
sions were calculated from all the data points. There-
sults of those calculations are shown in Table 8. For 
each protein, the degradation rate constant, k (hr-1), was 
determined from the slope of the log plots of cpm remain-
ing vs time (Figures 13 - 23). In general, the rate con-
stant, k, decreases with increasing molecular weight. The 
results are shown graphically in Figure 25. 
G. Effect of Various Factors on Protein Degradation 
The observation that the degradation of radio-la-
beled proteins by macrophages was reproducible and 
Figure 24. Plot of (cpmt-cpmr)/cpmt versus the 
log of the subunit molecular weight of the protein. 
a) Least squares line for all data points 
but BSA and Thyroglobulin. Correlation 
coefficient equals 0.952. 
b) Least squares line for all data points 
but BSA, thyroglobulin, and B-Galacto-
sidase. Correlation coefficient equals 
0.962. 
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Figure 25. Plot of the apparent first order rate con-
stant vs the log of the subunit molecular weight of 
the protein. Each point represents the mean + stan-
dard deviation. The least squares line for all points 
but BSA and thyroglobulin is indicated. Correlation 
coefficient = 0.928. 
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reflected the activity of a proteolytic enzyme system 
within the cell prompted us to investigate additional 
properties of this system. In order to determine if the 
rate of degradation of BSA was directly proportional to 
its concentration in the cells, the specific activity of 
1 2 5 
the !-labeled protein was decreased by adding varying 
amounts of cold BSA to the uptake media, As shown in 
Table 9 there was no difference in the amount of label re-
leased by 30 hours when cells were previously exposed to 
0, 0.1, or 1.0 mg/ml of cold BSA along with labeled BSA. 
This was the result expected for a system in which the 
rate of degradation of BSA is first order in substrate con-
centration. In this range of BSA concentration, it was 
not possible to saturate the degradative enzymes with un-
labeled BSA. In a related experiment, different amounts 
of labeled BSA were added to the uptake media. The 
7 amounts were 0.2, 0.4, 0.6, 0.7, 1.2, and 1.5 x 10 
cpm/ml. In all cases, the amount of TCA soluble label 
released with time was directly proportional to the amount 
of label taken up by the cells (Table 10). 
Cells were s,imultaneously loaded with dextran-sul-
1 2 5 
fate (1 mg/ml) and I-BSA to determine if the presence 
135 
TABLE 9 
1 2 5 
Release of Label From Cells With I-BSA Endocytosed 
in the Presence of Cold BSAa 
Cold BSA Added 
(mg/ml) 
a 
0 
0.1 
1.0 
cpmt-cpmr at 30 Hours 
cpmt 
0.31,0.30 
0.28,0.29 
0.30,0.30 
Uptake was performed in media with no FCS for 18 hours. 
125 7 
The I-BSA was present in the media at 1 x 10 
cpm/ml (O.OOSmg/ml). 
136 
TABLE 10 
Release of Label From Cells Incubated '.Jith Varying 
Amounts of Labeled BSAa 
a 
cpm/ml x 106 
1 2 5 
I-BSA 
2 
4 
6 
7 
12 
15 
cpmt 
at 10 hours 
0.48,0.60 
0.54,0.62 
0.50,0.62 
0.48,0.62 
0.51,0.57 
0.56,0.58 
Uptake was performed in media with 50% FCS for 19 hours. 
137 
of dextran-sulfate in the uptake media could affect the 
1 2 5 
subsequent degradation of I-BSA. This experiment was 
performed because we contemplated using dextran-sulfate 
as a carrier for introducing proteinase inhibitors into 
these cells. As can be seen from Figure 26, dextran-sul-
fate can itself inhibit the release of TCA-soluble radio-
activity when administered simultaneously with the sub-
strate. In contrast, when dextran-sulfate was added to 
1 2 5 
the release media after uptake of I-BSA alone, it had 
no effect on the rate of degradation of BSA. 
The effect of varying the concentration of fetal 
calf serum in the release media was also investigated. 
In Figure 27 it can be seen that the release of TCA sol-
1 2 5 
uble radioactivity from I-BSA laden macrophages and 
fibroblasts is inhibited in the presence of 50% FCS. In 
addition, the percentage of label regurgitated as TCA 
insoluble radioactivity increases from about 25% to 50%. 
To determine if these differences could be due to 
changes in the precipitability of labeled products in the 
1 2 5 
presence of varying levels fetal calf serum, I-BSA 
laden fibroblasts were allowed to release label into 
Figure 26. Release of radioactivity from macro-
phages incubated overnight with 1 x 107 cpm/ml 
125 125 
I-BSA (*) and I-BSA plus dextran-sulfate 
( o ). All values represent averages from 2 
samples. 
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Figure 27. Release of TCA soluble radioactivity from 
macrophages and fibroblasts incubated overnight with 
1 x 107 cpm/ml 
1 2 5 
I-BSA in 50% FCS. The labeled cells 
were incubated in media with 1% FCS (+) or 50% FCS 
( D ) and media samples removed at each time point 
for analysis. Each point is the average value from 2 
duplicate plates. 
a) Macrophages 
b) Fibroblasts 
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media containing 1% fetal calf serun. Media samples were 
removed at varying times and fetal calf serum was added 
to half of each sample before precipitation with TCA. The 
addition of fetal calf serum had no effect on the amount 
of TCA insoluble radioactivity present in each sample in-
dicating that the increase in precipitable radioactivity 
seen in release experiments in 50% fetal calf serum was 
due to an increase in the amount of incomplete or non-
digested protein regurgitated by the cells and not to an 
increased precipitability of labeled protein in 50% fetal 
calf serum. 
H. Effect of Protein Conformation on Protein Degradation 
In order to determine the effect of denaturation 
on the rate of degradation of pinocytosed proteins, prep-
1 2 5 
arations of I-BSA which had been boiled for 10 min-
utes were preincubated with macrophages and the rate of 
release of TCA soluble radioactivity measured. The dena-
turation of BSA by this method was verified by analyzing 
1 2 5 
the boiled I-BSA with the Affi-gel blue affinity col-
umn. The percent bound by the column decreased from 80% 
to 30% after boiling. Denatured BSA was degraded at a 
rate only slightly faster than that of the native protein 
(Figure 28). This suggests that, for BSA, protein 
Figure 28. Release of TCA soluble activity from 
macrophages incubated overnight in 1 x 107 cpm/ml 
125 6 
I-BSA (+) or 2 x 10 cpm/ml heat-treated 
1 2 5 
I-BSA ( o ) . Each point represents the average 
of 2 experiments for the heat-treated BSA and 7 
experiments for the untreated BSA. The least squares 
line for each is indicated. 
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denaturation may not be the rate determining step in its 
degradation in lysosomes. During the course of our 
studies, it was observed that solutions of a-galactosi-
dase which had been frozen and thawed were degraded more 
rapidly than samples not treated in this manner. This is 
shown in Figure 29. This progressive increase in the 
rate of degradation with successive cycles of freezing 
and thawing was shown to be correlated with a loss in en-
zymatic activity (Table 11). Clearly, for a-galactosi-
dase, a protein normally degraded slowly in macrophages, 
denaturation produced a marked increase in its lysosomal 
degradation rate. This effect of freezing and thawing 
on B-galactosidase was not observed with the other pro-
teins studied when they were frozen and thawed. 
I. Relation Between Time of Uptake and Degradation Rate 
If the nonlinear release curves are due to the 
presence in protein substrates of peptide bonds with dif-
ferent susceptibilities to cleavage by proteinases, then 
one would expect that partially degraded intermediate 
species to accumulate in cells. Since the release exper-
iments described in the previous sections were performed 
after 18 hours of uptake of label, one would expect that 
Figure 29, Release of TCA soluble radioactivity 
from cells incubated overnight in freshly labeled 
1 2 5 
I-S-galactosidase (+) and frozen and thawed 
1 2 5 
I-S-galactosidase ( o ) . Each sample was run 
in duplicate. The least squares line for ea,ch_ is 
indicated. 
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TABLE 11 
Effect of Freezing on the Activity of S-Galactosidase 
Sample 
Before freezing 
After freezing 
a 
a 
A/t X 10-4 
b 15.2(15.4,14.9) 
5.9 + 0.3c 
% of Initial 
Activity 
38.8 
Activity is expressed as the change in absorbance at 
4 0 d 10-4. 1 nm per secon times The S-galactosidase 
(100 ~1 of a 0.2 ~g/ml solution) is preincubated for 5 
minutes with 300 ~1 mercaptoethanol (1 M) before the 
addition of o-nitrophenyl, 6-D-galactopyranoside. 
bAverage of 2 determinations. Two values obtained in 
parentheses. 
c 
Mean of 4 determinations + standard deviation. 
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that these cells had accumulated quantities of poly-
peptide fragments more resistant to further degradation 
having already released amino acids from the most sus-
ceptible regions of the molecule. To confirm this hypoth-
1 2 5 
esis, cells were allowed to accumulate I-BSA for just 
one hour. The cells were then washed and incubated in 1% 
fetal calf serum and the rate of release of TCA soluble 
radioactivity measured. With a one hour uptake, the ini-
tial rate of release of TCA soluble label into the media 
is more rapid, and the nonlinearity of the logarithmic 
plot is more apparent (Figure 30) . This· was observed in 
both macrophages and fibroblasts. In contrast, the per-
centage of the label released in the TCA insoluble form 
is the same after a one hour uptake as after the overnight 
1 2 5 
uptake. The degradation of heat denatured I-BSA after 
one hour uptake was also studied (Figure 31). Again, the 
TCA soluble label released after a 1 hour uptake is ini-
tially more rapid and a greater percentage of label is 
released in the rapid phase. 
The effect of a one hour uptake on the rate of 
release of TCA soluble label was studied utilizing the 
protein substrates described previously (Figures 32 ~ 331: 
It was found that phosphorylase b and thyroglobulin each 
showed an increased rate of degradation and an increase 
150 
Figure 30. Release of TCA soluble radioactivity from 
macrophages incubated overnight ( a ) or 1 hour ( a ) 
1 2 5 
with I-BSA. The 1 hour data is presented as the 
mean+ standard deviation for 3 experiments. 
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Figure 31. Release of TCA soluble radioactivity from 
macrophages incubated overnight ( • ) or 1 hour ( a ) 
l 2 5 
with heat-treated I-BSA. The 1 hour data is pre-
sented as the mean+ standard deviation for 3 experiments. 
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Figure 32. Release of TCA soluble radioactivity from 
macrophages incubated overnight ( • ) or 1 hour ( a ) 
1 2 5 
with !-phosphorylase b. The 1 hour data is pre-
sented as the mean + standard deviation for 3 exper-
iments. 
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Figure 33. Release of TCA soluble radioactivity from 
macrophages incubated overnight (~ ) or 1 hour ( ~ ) 
with 125!-thyroglobulin. The 1 huur data is presented 
as the mean+ standard deviation for 3 experiments. 
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in the proportion of label released during the rapid 
1 2 5 
phase. In contrast, the degradation rates of !-
ovalbumin were not much affected. However, in most 
158 
cases, the proportion of the total labeled protein re-
leased at the slower rate had been decreased. 
Rate constants for the release of labeled uroteins 
endocytosed for 1 hour were calculated as before. The 
results are shown in Table 12. 
J. Inhibitors 
Finally, the effect of protease inhibitors on the 
1 2 5 
release of label from endocytosed I-BSA was studied. 
The inhibitors studied included leupeptin and antipain 
for cathepsin B and pepstatin for Cathepsin D. An al-
tered release of label was observed only when the inhib-
itors were added to the uptake media along with the la-
beled BSA for the overnight incubation. There was· no ef-
fect observed when the inhibitor was added to the release 
media only. This result is understandable for pepstatin 
since it is only taken up by pinocytosis (161} and does 
not enter the cell quickly. The explanation for this 
result for leupeptin and antipain is not known since 
these inhibitors are reported to be able to permeate the 
plasma membranes of macrophages (22) . 
TABLE 12 
Calculated Rate Constants and Y-Intercepts For 
1 Hour and Overnight Uptake Experiments 
Apparent First Ordera 
Rate Constant (X 103) Y-Interceptb 
Protein Overnight 1 Hour Overnight 
Ribonuclease 22.3 + 3.7 26.6 + 2.0 
-
.333 
Arginase 18.5 + 0.8 16.5 + 1. 3 - .136 
Ovalbumin 12.6 + 1.6 7.8 + 0.6 - .185 
BSA 27.3 + 0.8 22.6 + 2.0 - .236 
Phosphorylase b 11.0 + 1.2 28.6 + 1. 9 - .029 
Thyroglobulin 17.5 + 0.9 27.0 + 1.2 - .135 
Denatured BSA 21.2 + 1.9 31.6 + 3. 7 - .430 
aCalculated from all data points. Value given is mean + standard 
deviation. 
bCalculated from all data points after 8 hours. 
1 Hour 
- .558 
- .216 
- .164 
-
.628 
- .454 
- .388 
- .972 
........ 
IJ1 
\0 
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Figure 34 illustrates the release of label in the 
presence of the various inhibitors. Pepstatin 
(8.8 x 10-~) retarded the release of TCA soluble radio-
activity from the macrophages. Leupeptin (6.6 x 10-~) 
and antipain (4.9 x 10-~) which inhibit lysosomal syste-
ine proteinases, appeared to cause-an increased release 
of label. The percentage of label released in the ini-
tial rapid phase decreased with pepstatin and increased 
with leupeptin and antipain. The experiment was re-
peated using chloroquine (1 x 10-~). a lysosomotropic 
agent, which is known to become concentrated within the 
lysosomes where it disrupts intralysosomal pH and may 
additionally inhibit cathepsin B and other lysosomal pro-
teases. It is also known to induce autophagy (143). 
Chloroquine greatly inhibited the release of label into 
the media. Dextran-sulfate also inhibited the release of 
label into the media (Figure 35) . Its effects· on the 
proteases papain, cathepsin B, and trypsin are shown in 
Figure 36. 
The effect of inhibitors on regurgitation of TCA 
insoluble labeled protein into the media was also in-
vestigated (Table 13). Leupeptin and pepstatin caused 
a slight decrease in the percentage of TCA insoluble 
161 
Figure 34. Release of TCA soluble radioactivity from 
7 125 
macrophages incubated with 1 x 10 cpm/ml I-BSA 
incubated in the presence of pepstatin, 60 ~g/ml ( ~ ), 
chloroquine, 50 ~g/ml (0), leupeptin, 290 ~g/ml <•), 
and antipain, 290 ~g/ml (D). All values from 3 
experiments are given for the inhibitor studies. The 
rate constants calculated for the degradation of 
1 2 5 
I-BSA in the presence of inhibitors are 0.047 
(antipain), 0.036 (leupeptin), 0.011 (pepstatin), ~nd 
0.006 (chloroquine). 
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Figure 35. Release of TCA soluble radioactivity from 
macrophages incubated overnight with 1 x 107 cpm/ml 
1 2 5 
1-BSA alone (*) or in the presence of dextran 
C 0 ) or dextran-sulfate ( a ) at 1 mg/ml. The control 
and dextran experiments were performed in duplicate. 
The dextran-sulfate data represents the average of 4 
samples. Plotted is the% of total counts per minute 
released during the initial rapid phase vs time. 
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Figure 36. The inhibition of papain(*), cathepsin 
B (D), and trypsin (0) by dextran-sulfate. The 
concentration of dextran-sulfate is plotted against 
the percent of the unhibited activity remaining at 
that concentration. 
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TABLE 13 
Release of TCA Insoluble Radioactivity From Endocytosed 
1 2 5 
I-BSA in the Presence of Inhibitorsa. 
Inhibitor Added 
None 
Anti pain 
Leupeptin 
Pepstatin 
Chloroquine 
% Released as TCA 
Insoluble 
27.6 + 3.8b 
-
25.3 + 4.4c,d 
-
15.7 + 3.0c,e 
-
14.3 + 3.0c,e 
f 36.5 (30.6,42.1) 
aRelease of Label was performed for 28 hours in media 
containing 1% FCS. 
bAverage of 4 determinations 
c Average of 3 determinations 
dDifference from control not statistically significant 
eDifferences from contro-l- statistically significant 
(p<. 025) 
£Average of 2 determinations. 
Data not sufficient to determine statistical significance 
of the difference from control values. 
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radioactivity released while chloroquine caused a slight 
increase. Antipain had almost no effect. 
These inhibitor experiments were also repeated with 
cells which had been loaded with labeled protein and in-
hibitor for only 1 hour. Inhibitors were also present in 
the release media. The results are shown in Figure 37. 
Leupeptin and pepstatin now both appear to have little 
effect. Chloroquine, however, caused an inhibition of 
the release of label. 
169 
Figure 37. Release of TCA soluble radioactivity from 
macrophages preincubated for 1 hour with 4 x 10 7 cpm/ml 
1 2 5 
I-BSA in the presence of pepstatin, 60 ~g/ml ( 0), 
leupeptin, 290 ~g/ml (0), and chloroquine, 50 ~g/ml ( ~ ). 
The release with no inhibitors present is also shown 
(+) . From 2 experiments are given for the inhibitor 
studies. 
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CHAPTER IV 
DISCUSSION 
A. Exoerimental Techniques 
The uptake and digestion of extracellular proteins 
by macrophages was studied by Ehrenreich and Cohn (104). 
In their experiments, cells were maintained in glass 
T-flasks after collection and protein uptake and degrada-
tion studies were performed in these flasks. The general 
procedure was as follows: Iodinated HSA, in a concentra-
tion of 106-107 cpm/ml, was added to approximately 
8 x 106 cells in medium 199 containing 50% newborn calf 
serum. After appropriate uptake times, cells were washed 
with isotonic saline. Cell associated radioactivity was 
then collected by repeated freezing and thawing in dis-
tilled water. Protein degradation studies were performed 
by adding fresh media after the washing step and collect-
ing all the cells in a flask for each time point in the 
experiment. They also collected the media at each time 
point and measured TCA soluble and insoluble radioactivity 
present. They reported that the increase in the TCA solu-
ble radioactivity in the media with time was about equal:i.n 
magnitude to the decrease in cell-associated radioactivity. 
171 
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The amount of TCA insoluble label in the media showed no 
consistent change and was attributed to intact protein 
remaining from the pulse. Because of the large quanti-
ties of cells required forT-flasks, we attempted to 
adapt the methodology of Cohn and his associates to quan-
tities of cells which could be grown on glass coverslips 
immersed in media or on the bottom of small glass culture 
dishes. These efforts were unsuccessful. In attempting 
to locate the sources of error in the methodology, we 
found that glass culture plates and coverslips were the 
main causes of our difficulties. It was observed that 
iodinated proteins were nonspecifically adsorbed to glass 
surfaces. This radioactivity was firmly bound and was not 
totally removed with subsequent washing. However, on incu-
bating these surfaces with fresh media, the radioactivity 
was slowly released. Some of this labeled protein could 
also be released by repeated freezing and thawing of the 
plates. This led to anomalously high estimates of the 
amounts of labeled protein taken up by the cells, of the 
amounts of labeled protein subsequently released by· the 
cells, and of the amounts of cell-associated radioactiv-
ity remaining at the end of the release experiment, These 
173 
errors were significantly reduced by performing all exper-
iments in plastic culture dishes. Also, it was found that 
sonicating the plastic culture plates, in contrast to 
repeated freezing and thawing, could release the cell as-
sociated radioactivity in preference to the non-specifi-
cally bound label. Following sonication of the plates, 
microscopic examination revealed very few if any attached 
intact cells remaining. 
Our method for measuring protein uptake and degra-
dation, therefore, relied on the use of plastic multi-
plates with sonication to release the cell associated la-
beled protein. Degradation studies were performed by col-
lecting aliquots from the media at various times during 
the experiment and by collecting the cell associated radio-
activity remaining at the end of the experiment. To dis-
tinguish radioactivity arising from protein degradation 
from the release of intact protein, each aliquot of media 
was treated with TeA-phosphotungstic acid and the soluble 
radioactivity measured. With this techniaue, all the data 
points in a single experiment could be obtained from a 
single culture plate. This resulted in improved preci-
sion because it was not necessary to apply uncertain 
174 
corrections for differences in cell numbers between 
plates. Uncertainties arising from differences between 
plates in the amounts of labeled protein taken up by the 
cells were also avoided. In addition, the sensitivity 
was sufficiently great so that an entire experiment could 
be done with 4 x 106 cells. This made it possible for 
several experiments to be performed concurrently using 
pooled cells from 4 to 8 animals. 
The media samples collected were precipitated with 
TeA-phosphotungstic acid and the soluble and insoluble 
radioactivity determined for each time point. In agree-
ment with Ehrenreich and Cohn, we found that the TCA-sol-
uble counts increased with time. However, in contrast to 
their results, we also found a significant time dependent 
release of TCA insoluble radioactivity. This difference 
may be due to the fact that the other workers were unable 
to measure small changes in the level of TCA insoluble 
radioactivity against a large background resulting from 
the release of TCA insoluble labeled protein non-specif-. 
ically adsorbed to their glass culture flasks, In our 
experiments, we were able to observe that the sum of the 
TCA insoluble and soluble counts released equaled, within 
175 
experimental error, the amount of label lost by the cells. 
The reproducibility of this technique is demon-
strated in Table 14. This table summarizes the data ob-
1 2 5 
tained for I-BSA, our most thoroughly studied protein. 
B. Uptake of Substrates 
The uptake by cultured macrophages of the non-
1 4 
digestible labeled polymer, C-dextran-sulfate, was 
found to increase with time with its concentration in the 
medium. We were able to calculate an endocytotic index 
(EI) (105) which is defined as the volume of media in 
order for them to have accumulated a measured amount of 
radioactive material. For a non-receptor mediated uptake, 
the endocytotic index should be independent of the con-
centration of labeled polymer in the medium. For recep-
tor mediated uptake, the endocytotic index should appear 
to decrease with increasing concentration of the label. 
In agreement with the literature (112), the endocytotic 
index for dextran-sulfate was found to be greater than 
that measured for dextran and was also observed to be 
concentration independent. 
1 2 5 
Studies on the uptake of I-BSA by cultured 
macrophages appeared to indicate that the process was 
Table 14 
1 2 5 
I-BSA Release Experiments 
1 2 5 
Cell Batch I-BSA (cpmt-cpmr) /cpmt 
Number Batch Number 1 Hr 2 Hr 3 Hr 4 Hr 5 Hr 6 Hr 9 Hr 24 Hr 
1 1 .963 .905 .875 .834 - .740 .667 .341 
1 1 .941 .907 .866 .837 - .760 .. 676 .343 
1 1 .967 .877 .855 .824 - .703 .581 .229 
1 1 .934 .873 .859 .790 - .694 .633 .283 
2 2 .972 .891 .895 - .853 - - .552 
2 2 .943 .856 .856 - .728 - - .421 
2 2 .970 .897 .900 - .825 - - .496 
2 2 .933 .908 .944 - .841 - - .425 
6 3 .962 .936 .920 .904 .840 .814 .721 .420 
1-' 
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I-BSA Release Experiments 
1 2 5 
Cell Batch I-BSA (cpmt-cpmr) /cpmt 
Number Batch Number 1 Hr 2 Hr 3 Hr 4 Hr 5 Hr 6 Hr 9 Hr 24 Hr 
6 3 .972 .939 .902 .861 .835 .815 .708 .459 
12 4 .974 .929 - .856 - .827 - .467 
14 4 - .911 .936 .885 .838 - .700 .483 
15 4 .943 - .934 .915 .848 - .744 .356 
15 4 .983 .937 .922 .902 .832 - .828 .500 
15 4 .961 - - - .858 - .779 .513 
15 4 .966 .934 .919 .858 .845 - .769 .465 
15 4 .958 .949 .931 .899 .816 - .700 .393 
16 4 - - - - - .830 .779 
1-' 
......... 
......... 
Table 14 (Cont'd.) 
1 2 5 
I-BSA Release Experiments 
1 2 5 
Cell Batch I-BSA (cpmt-cpmr) /cpmt 
Number Batch Number 1 Hr 2 Hr 3 Hr 4 Hr 
--
18 4 - - .848 .793 
19 4 .912 .864 .804 .784 
19 4 .922 .850 .810 .784 
20 5 - .910 - -
20 5 .933 - .820 -
Mean .953 .904 .884 .848 
Standard Deviation .020 .030 .044 .047 
5 Hr 6 Hr 
- .727 
-
.703 
-
.724 
.770 -
.793 
-
.823 .758 
.047 .054 
9 Hr 
.629 
.604 
.590 
-
-
.694 
.074 
24 Hr 
.447 
.406 
.399 
.481 
.423 
.079 
t-' 
....... 
00 
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not receptor mediated. This was supported by the obser-
vation that the uptake mechanism could not be saturated 
with increasing concentrations of labeled BSA in the media 
(Table 2) and by the observation that increasing amounts 
of cold BSA did not inhibit the uptake of label (Table 3). 
In both cases, the endocytic index measured after an over-
night uptake was independent of BSA concentration. 
The EI for BSA was less than those for the non-
digestible substrates. This could be due to ongoing pro-
tein degradation during uptake since the amount of label 
accumulated by cells in a 24 hour period increases in the 
presence of protease inhibitors. The uptake of BSA was 
also increased in the presence of dextran sulfate. This 
might have been due to the inhibition of degradation since 
dextran sulfate was found to inhibit release of TCA sol-
uble radioactivity (Figure 26). It could also have been 
due to an increase in pinocytosis by cells in the presence 
of dextran sulfate (112} or to the formation of non .. 
covalent dextran sulfate-protein conjugates which are 
taken up by the cells (144) . 
The uptake of BSA is also increas·ed following denat-
uration by boiling. Similar results have been reported 
for formalin-treated BSA with rat yolk-sac (107) . This 
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increased uptake is not due to decreased degradation in 
the lysosomes as the rate of release of TCA soluble radio-
activity from the denatured BSA was slightly greater than 
that from native BSA (Figure 12). Instead, it may have 
been due to the exposure of hydrophobic regions of the 
protein on denaturation with a concomitant increase in 
non-specific adsorption to the plasma membrane of the 
cells. In contrast, a-galactosidase denatured by freez~ 
ing and thawing had a decreased overnight uptake, hut 
this was probably due to its much increased rate of deg-
radation after denaturation (Figure 29). 
C. Release of Labeled Substrates 
Cells loaded with non-digestible substrates were 
found to release label in a rapid initial phase followed 
by a very slow steady release which continued for at 
least 24 hours (Figure 8). This is in agreement with_· 
studies previously reported (1051. 
Cells loaded with labeled protein were found to 
release both TCA insoluble and soluble radioactivity with 
time (Figure 9) . The time course of the release of TCA 
insoluble label resembled that of the release of 
1 4 
C-dextran-sulfate by cells; there was a rapid initial 
release followed by a slow continuous release of label. 
1.81 
This TCA insoluble label in the media was shown by gel 
exclusion chromatography to be associated with a large 
molecular weight fraction (Figure 11). It has previously 
been suggested that macrophages are capable of regurgita-
ting the contents of some of the endocytic vesicles back 
into the media (105) . The amount of TCA insoluble label 
released is greater when the release ~edia contains 50% 
FCS as compared with 1% FCS (Figure 27). This could be 
due to an increased membrane activity induced by fetal 
calf serum (110, 111). 
Because of this release of TCA insoluble label, all 
media samples collected were precipitated 'tvith TCA s·o that 
the counts due to TCA insoluble and soluble label could 
be distinguished. In order to assess the true rate of 
lysosomal protein degradation, it was necessary to correct 
for the release of intact labeled protein from the cells 
as described in the results section. 
The TCA soluble label released by cells preloaded 
1 2 5 
with I-BSA was also analyzed by column chromatography 
(Figure 11) and was found to be composed of low molecular 
weight labeled products (MW > 300) in agreement with the 
results of others (104, 126-129). When data from the time 
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course of release of TCA soluble labeled products were 
analyzed graphically for a first order reaction, the 
experimental points did not appear to fall on a straight 
line. Thus, the rates of release of soluble products 
during the late intervals in the reaction were slower 
than expected on the basis of the data collected during 
the early stages. This was particularly apparent in 
those experiments in which the cells had been pre-ex-
posed to labeled substrates for only a short period 
(1 hour). Compare, for example, Figures 30 through 33. 
Similar non-linear semi-log plots have been obtained when 
native proteins are treated with proteinases in vitro, 
and is probably due to a heterogeneity of the microenvi-
ronments in which the labeled amino acids residues reside 
in the intact protein. This causes the labeled residues 
to be released from the protein at different rates. 
Other possible explanations for the non ..... linearity 
of the semi-log plots of the release data were also con-
sidered. These include heterogeneity in the cell popula-
tions, heterogeneity in the lysosomal populations 1 and 
heterogeneity in the substrates themselves. If either the 
first or second exnlanation was correct 1 the findings _,. 
that the rate of release of label during the late stage, as 
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well as the relative proportion of label released during 
the early and late stages varied in a systematic way with 
the size of the protein substrate would require mechanisms 
for the selective uptake of large and small proteins into 
different cell types or the selective sequestration of 
large and small proteins into endocytic vesicles of dif-
ferent hydrolytic capacities. ~1hile the possibilities can 
not be excluded, the absence of any precedents for such 
behavior together with difficulties in conceptualizing how 
such mechanisms might work makes these possibilities seem 
less likely. The possibility that the substrates them-
selves are heterogeneous is not consistent with the find-
ing that the shapes of the curves obtained with BSA were 
similar between the various batches of BSA used, were only 
slightly affected by heat denaturation, and could not be 
eliminated by subsequent purification of the protein by 
affinity chromatography. Similarly, the apparent biphasic 
degradation patterns observed with some of the smaller 
protein substrates, which. exhibited a substantial fast 
phase, would require a substantial heterogeneity which was 
not observed when these proteins were subjected to either 
agarose or polyacrylamide gel electrophoresis prior to 
labeling. In contrast, the apparent biphasic degradation 
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patterns observed with large molecular weight proteins, 
which characteristically exhibited a small initial rapid 
phase, might have been due to the presence of low levels 
of denatured protein or other protein contaminants. 
A final possibility which must be considered is that 
the method of labeling of protein results in a heteroge-
neous population of labeled protein. This will be discus-
sed in greater detail in reference to differences in the 
rates of degradation of large and small proteins. For now 
it is sufficient to say that no differences in the appar-
ent degradation rates of protein were observed when they 
were labeled by either the chloramine T method or the 
lactoperoxidase method. Moreover, even if the distribu-
tion of label within a protein were not the same for each 
molecule, the non-linear semi-log plots still imply that 
different labeled residues are released at different rates. 
The existence of apparent biphasic degradation 
curves for the various labeled proteins employed in these 
experiments implies that cells can accumulate with time 
labeled materials which are more resistant to subsequent 
proteolysis than the original protein substrate. Since 
the period of uptake of the various labeled proteins 
was usually about 24 hours, one might expect that these 
labeled cells had accumulated significant amounts of 
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resistant peptide fragments by the time the degradation 
studies were initiated. By decreasing the time of uptake 
of labeled substrates to one hour, one might expect to 
see a significant increase in the apparent rate of degra-
dation and in the extent of the initial rapid phase. 
In addition, this effect should be more exaggerated for 
the large molecular weight proteins which had exhibited 
the greatest differences in the rates and extents of the 
fast and slow degradation phases. A comparison of the 
results in Figures 30, 32, and 33 show that these expecta-
tions were realized. 
As a further test of the hypothesis that cells can 
accumulate labeled polypeptide intermediates, the cell 
associated radioactivity following a 20 hour uptake of 
labeled BSA was subjected to gel exclusion chromatography. 
The elution pattern was characteristic of a polydispersed 
system containing high, intermediates, and low molecular 
weight radioactive material (Figure 11). 
The effect of protease inhibitors on the release of 
TCA soluble radioactivity was studied. Pepstatin, which 
inhibits cathepsin D was added to the uptake media at a 
concentration of 60 ~g/ml and was found to inhibit the 
1 2 5 
degradation of I-BSA (Figure 34), No e.ffect wa,s 
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observed when pepstatin was added only to the release 
media after the initial 20 hour uptake period. Similar-
ly, pepstatin had no effect on degradation when added to 
the uptake media when the duration of uptake was limited 
to one hour. These results are consistent with the con-
elusion that the uptake of pepstatin into cells is by 
endocytosis rather than by passive diffusion, Chloro-
quine, a lysosomotropic reagent which alters intralysoso-
mal pH and which inhibits cathepsin B and other lysosomal 
1 2 5 
proteases (143), also inhibited the degradation of I-
BSA which had been taken up by macrophages (Figure 34). 
This inhibition occurred irrespective of whether chloro-
quine was added during the uptake period or during the 
release period in agreement with earlier findings that 
chloroquine can rapidly penetrate the cell by passive 
diffusion (145). In contrast to these results, leupep-
tin and antipain, inhibitors of cathepsin B1 and other 
lysosomal thiol dependent proteases, actually enhanced 
1 2 5 
the apparent rate of degradation of I-BSA, However, 
the concentrations of inhibitors used in these expriments 
were high (290 ~g/ml) and part of their effect could be 
due to other actions on the cells. Since the olasma mem-
" 
branes of some cells are permeable to these inhibitors it 
is not possible to rule out an extra lysosomal site of 
action. In addition, the presence of these inhibitors 
in long-term culture of newborn heart cells has been 
found to actually cause an increase in the level of 
cathepsin B in these cells (151) . As a consequence of 
these considerations, the results we obtained with 
leupeptin and antipain are difficult to interpret. 
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There is a substantial body of evidence in the lit-
erature which indicates that denatured proteins are de-
graded more rapidly by proteases in vitro than are native 
proteins. This may be due to an increase in the accessi-
bility of previously buried peptide bonds in the dena-
tured state or to an increased conformational flexibility 
of the peptide backbone in the denatured state, Intui-
tively, therefore, one might expect denaturation to have 
a greater effect on the degradation rates of large pro-
teins, since these contain a greater proportion of buried 
peptide bonds and are degraded more slowly in the native 
state in vivo. A comparison of the degradation rates for 
native and denatured BSA and B-galactosidase in Figures 28 
and 29 confirm this expectation. Thus, while the dena-
tured protein was degraded more rapidly than the native 
protein in both cases, the effects of denaturation were 
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much greater for the larger S-galactosidase than for BSA. 
One complication in interpreting the results of 
such denaturation studies is that we have no assurance 
that the denatured states of these two proteins in dilute 
aqueous solution are in any way equivalent, since our 
definition of denaturation is simply a loss of biological 
activity. For BSA, the absence of biological activity 
was judged by the failure of the heat treated protein to 
bind the ligand conjugated to agarose in the affi-gel blue 
column. For B-galactosidase, denaturation was judged by 
the loss of enzymic activity following repeated freezing 
and thawing of dilute aqueous solutions of the enzyme. 
D. Protein Structure and Degradation Rate 
There appeared to be a relationship between the 
subunit molecular weights and the degradation rate.s of 
the various protein substrates. studied (figure 24). We · 
have previously suggested that th.e non-linear semi-
logarithmic plots of our degradation data were due to dif-
ferences in the susceptibilities of various pepti.de bonds 
to proteolytic cleavage. Moreover, the increase in the 
rate of degradation of denatured B-galactosidas:e may have 
been due to an increased exposure of normally buried pep-
tide bonds in the denatured state, This leads to th.e 
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idea that the degradation rates of various proteins should 
in some way be related to the fraction of the total number 
of peptide bonds exposed to solvent and thus accessible 
action of the lysosomal proteases. Since the surface area 
of a sphere varies with the square of its radius while its 
volume varies with the cube of its radius, the ratio of 
surface area to volume should be inversely proportional to 
its radius (A/V ~ 1 K). Therefore, for a series of glob-
ular proteins which approximate spheres, one would expect 
that the fraction of peptide bonds accessible to proteases, 
and thus the apparent degradation rate might b~ propor~ 
tional to the inverse of the subunit radius. Figure 38 
shows a plot of 1/relative subunit radius vs tne log of 
the fraction of undigested labeled material remaining in 
the cell after 35 hours for the various proteins in this 
study. In this plot, r was calculated by assuming that 
all the proteins or protein subunits were spheres of equal 
density. 
A relative r was then calculated by setting r for 
cytochrome c equal to 1. As can be seen, a straight line 
can be drawn through most of the data points. Two pro-
teins whose degradation rates deviate markedly from this 
line are thyroglobulin and BSA. In each case, both pro-
teins behave as if their subunit molecular weights were 
Figure 38. Plot of 1/relative radius versus the 
log of (cpmt-cpmr) /cpmt at 35 hours. Solid line, 
all the proteins except thyroglobulin, BSA and 
a-galactosidase; dashed line, all the proteins 
except thyroglobulin and BSA. 
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much smaller than expected. The anomalous behavior of 
thyroglobulin can be readily explained in terms of its 
structure and biological function. Characterization of 
thyroglobulin synthesized from thyroglobulin messenger 
RNA suggests that it is composed of two polypeptide 
chains of two polypeptide chains of 300,000 to 330,000 
molecular weight (146, 147). This protein appears to be 
highly susceptible to limited proteolysis so that when the 
isolated 660,000 molecular weight dimer is subjected to 
SDS disc gel electrophoresis in the presence of mercap-
toethanol, a variety of discrete bands are obtained 
with a range of molecular weights from 19,000 to 330,000 
(148). It has been suggested that the monomer consists of 
a linear array of a repeating peptide unit of molecular 
weight of approximately 19,000 (148, 149). On this basis, 
it would be expected that the thyroglobulin subunit could 
behave in our system as if it were much smaller than 
330,000. From our data, thyroglobulin appears to be com-
posed of subunits of average molecular weight of 32,000. 
The explanation for the anomalous behavior of BSA may be 
similar. Recent studies have shotvn that this orotein is 
rapidly cleaved by endopeptidases into smaller fragments 
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which retain important structural and functional features 
of the intact protein (150) . BSA thus behaves as if it 
were composed of several globular domains linked by short 
peptide segments. In our system, such a molecule might be 
expected to behave as if it were composed of smaller sub-
units. From our results, BSA appears to have an average 
subunit molecular weight of 17,000. 
E. Comparisons With Intracellular Protein Degradation 
The work by many authors cited in this dissertation 
indicate the possible existence of more than one pathway 
for intracellular protein degradation. One pathway ap-
pears to involve lysosomes and is sensitive to inhibition 
by lysosomal proteinase inhibitors and agents which. dis-
rupt lysosomal function. The second may involve an extra-
lysosomal degradative system. However, this conclus·ion is 
still controversial and others have proposed tha.t the lyso-
some is the major s·ite of cellular protein turnover. The 
work described in this dissertation was undertaken with 
the belief that the results might permit these two alter-
natives to be distinguished, 
Table 15 sunnnarizes some of the characteristics of 
intracellular protein turnover which must be explained by 
any description of this process. Figures 1 and 3 describe 
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the two types of alternative mechanisms which have been 
proposed. The model described in Figure 1 assumes· that 
cellular proteins are degraded primarily in lysosomes 
with the proteolytic steps being rate determining. Thus, 
the half life of a cellular protein is proported to be 
related to its inherent susceptibility to the cocbined 
action of the various proteolytic and peptidolytic activ .. 
ities in the lysosome. In order to account for differ-
ences in turnover rates between proteins, this model fur .. 
ther assumes that the transfer of proteins between the 
lysosome and other cellular compartments can occur in two 
directions. Thus, stable proteins are those which. escape 
the lysosome before significant degradation can occur, 
while short lived proteins are those which are. almost 
completely degraded wi.thin the period of their residency 
in the lysosome. Although no compelling evidence has 
ever been presented to s·upport a two way transfer of pro-
teins into the lysosome, it has been noted that lysos:omes 
themselves turn over, and it is conceivable that at s.ome 
point near the end of their lifetime they become "leaky.'' 
This model predicts that the properties of intracellular 
protein turnover should strongly resemble thos.e of lys.o-
somal protein degradation, 
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A second form of model 1 proposes that the rate 
determining step in cellular protein turnover is the 
transfer of the substrate into the lysosome. Accordingly, 
a steady state should exist in which the amounts of vari-
ous cellular protein substrates within the lysosome are 
related to the ratios of their rates of transfer into the 
lysosome and their rates of degradation within the lyso-
some. This model proposes that differences in turnover 
rates between proteins are largely due to differences in 
their rates of sequestration by lysosomes. Thi_s model, 
makes the following predictions: Increased protein turn-
over caused by nutritional deprivation re.sults from an 
increased rate of transfer of protein into the lysosome 
and is reflected in an increased size of the lysosomal 
substrate pool; low concentrations of lysosomal proteinase 
inhibitors should produce only a transient inhibition 
which diminishes as the substrate pool within the lysosome 
increases to a new steady state level; intermediate lev-
els of inhibitors should produce a more persistent inhibi-
tion, while high concentrations should block protein turn-
over and produce an extensive vacuolization of the cell. 
In agreement, it has been observed that the size and pro-
tein content of lysosomes is initially low in the fed state 
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in perfused rat liver, but increases in proportion to 
increases in protein turnover during amino acid depri-
vation (157, 158). In addition, the inhibition of pro-
tein degradation in cultured macrophages induced by 
chloroquine is accompanied by a profound increase in the 
number and size of vacuoles within the cell (88). The 
failure of lysosomal proteinase inhibitors to completely 
block cellular protein turnover may not be incompatible 
with models 1 and 2, because the large number of proteo-
lytic and peptidolytic activities within the lysosome 
may preclude the complete inhibition of this system by 
one or a few agents. A more serious objection may be the 
apparent lack of additivity of these inhibitions (72). 
The third model, described in Figure 3, proposes 
the existence of at least two pathways of cellular pro-
tein degradation. One pathway associated with lysosomes 
degrades most cellular proteins at a comparable rate 
which may depend on how rapidly portions of the cytoplasm 
are sequestered in lysosomes. The second pathway is 
extralysosomal and degrades various cellular proteins at 
different rates depending on their accessibility, their 
inherent susceptibility toward proteolysis, or the ease 
with which they undergo spontaneous physical or chemical 
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modification to a more susceptible form. Accordingly, 
long live proteins are relatively resistant to the action 
of this system and are degraded primarily in lysosomes, 
short lived proteins are sensitive to the action of the 
extralysosomal system and are degraded by it. Proteins 
with intermediate half-lives are degraded in varying pro-
portions by both systems. This model can account for dif-
ferences in degradation rates between proteins, for the 
inability of inhibitors to completely block protein turn-
over (Table 15), for differences in the sensitivity of 
short-lived and long-lived proteins to inhibition of deg-
radation (Table 15), and for the observation that starva-
tion, which increases the contribution of the lysosomal 
pathway, ameliorates the differences seen in the degrada-
tion rates between proteins. 
The work described in this dissertation allow a dis-
tinction to be made between some of the models described 
above. Thus, I have observed that small proteins are de-
graded more rapidly in the lysosome than are large pro-
teins despite the fact that small proteins turnover more 
slowly in vivo (Table 15). Similarly, I have observed no 
important differen-ces in the rate of degradation of acidic 
and basic proteins despite the fact that acidic proteins 
TABLE 15 
Comparison of Intracellular and Extracellular Protein Degradation8 
Physical Properties of Proteinsb 
Intracellular Proteins 
Long Half-Life Short Half-Life 
Low Molecular 
Weight 
Basic pi 
Normal Confor-
mation or Amino 
Acid Composition 
High Molecular 
Weight 
Acidic pi 
Abnormal 
Conformation 
or Amino Acid 
Composition 
Extracellular Proteins 
Long Half-Life Short Half-Life 
High Molecular 
Weight 
No Relationship 
Seen Between pi 
and Degradation 
Rate 
Normal Conformation 
Low Molecular Weight 
Normal Conformation 
Effect~ of Inhibitors on Protein Degradationc 
·Intracellular Proteins Extracellular Proteins 
Inhibitor Long. Half-Life Short Half-Life 
Ftital Calf Inhibits 10% No Effect Inhibits 29% 
Serum (10%) (10%) (50%) 
Pepstatin Inhibits 0-40% No Effect Inhibits 59% (10-100 }.lg/ml) 
Antipain Inhibits 18-28% (50 }.lg/ml) (60 }.lg/ml) (50 }.lg/ml) No Effect Increases 74% (50 JJg/ml) (290 }.lg/ml) 
~ 
\0 
00 
TABLE 15 (Cont'd.) 
Effects of Inhibitors on Protein Degradationc 
Intracellular Proteins Extracellular Proteins 
Inhibitor Long Half-Life Short Half-Life 
Leupeptin Inhibits 20-70% No Effect Increases 33% 
(10-50 1Jg/ml) (10 lJg/ml) (290 lJg/ml) 
Chloroquine Inhibits 20-70% Inhibits Inhibits 78% 
(10-50 1-1g/ml) 12-45% (50 1-1g/ml) 
(10-50 1Jg/ml) 
a The values for extracellular protein represent the values for our data 
at 24 hours degradation time. 
b References 17 - 33, 152. 
c References 22, 46, 68, 72, 73, 77, 85, 90, and 151. 
....... 
1.0 
1.0 
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appear to turnover more rapidly in vivo than do basic pro-
teins (Table 15). However, our samples were too limited 
to fully test the effect of pi on degradation rate. These 
observations indicate that the rate determining step in 
protein turnover is not proteolysis in the lysosome, argu-
ing against model 1. My results also suggest that the 
rate of lysosomal protein degradation is more sensitive to 
the effects of chloroquine and pepstatin than is the over-
all rate of turnover of cellular protein. The inhibitions 
by these reagents, which I have observed, more closely 
resemble those seen for the degradation of long-lived pro-
teins, and are clearly much greater than those observed 
for short-lived proteins (Table 15), supporting model 3. 
F. Summary 
This study characterized the processes of uptake and 
degradation of extracellular proteins by cultured macro-
phages and fibroblasts. It was found that labeled BSA was 
taken up by the macrophages at a rate that was proportional 
to its concentration in the medium and was independent of 
the amount of unlabeled BSA present. This result suggests 
that BSA uptake was either not receptor mediated or that 
it was not possible to saturate the receptors under the 
experimental conditions used. 
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Cells loaded with labeled proteins released TCA 
insoluble and soluble radioactivity into the medium. The 
appearance of TCA insoluble label may have been due to 
regurgitation of undegraded protein and its release was 
virtually complete by 6 hours. TCA soluble labeled prod-
ucts were released during the entire course of the exper-
iment and was due to degradation of the labeled protein 
within the cells. 
The initial rate of r'elease of the TCA soluble 
label was proportional to the amount of label taken up 
by the cells and therefore appeared to be first order in 
substrate. However, first order plots of the releas-e data 
were non-linear over time. This was interpreted to mean 
that labeled amino acid residues in different regions of 
the protein were cleaved at different rates. It was fur-
ther hypothesized that the slower degradation observed 
at later times was due to the accumulation of protein 
fragments more resistant to cleavage than the intact pro-
tein. In confirmation of this conclusion. it was- observed 
that short uptake periods resulted in increased rates of 
release of soluble degradation products. 
The release of TCA soluble label was inhibited by 
50% FCS, chloroquine, and pepstatin. This inhibition is 
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consistent with degradation having occurred in the lyso-
some. 
The overall rate of degradation of a protein was 
inversely proportional to its subunit size. This obser-
vation can be explained if it is assumed that the degrada-
tion rate of protein is proportional to the fraction of 
its peptide bonds exposed on the surface. For a spheri-
cal protein, this fraction should be inversely propor-
tional to its molecular radius. In confirmation, it was· 
shown that prior denaturation produced a greater increase 
in the degradation rate of a large protein than of a 
small protein. 
Finally, a comparison of our results with. those ob-
tained for cellular protein degradation argues against a 
model for the latter in which the rate determining step is· 
proteolysis in the lysosome. Instead, a model involving 
both lysosomal and extra-lysosomal degradative sys;tems in 
cellular protein turnover is favored, 
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